Defining the role of IL-15 trans-presentation by distinct cell-types during the development and homeostasis of Natural Killer and invariant Natural Killer T cells by Castillo, Eliseo F
Texas Medical Center Library
DigitalCommons@The Texas Medical Center
UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences
8-2010
Defining the role of IL-15 trans-presentation by
distinct cell-types during the development and
homeostasis of Natural Killer and invariant Natural
Killer T cells
Eliseo F. Castillo
Follow this and additional works at: http://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Cell Biology
Commons, Developmental Biology Commons, and the Immunity Commons
This Dissertation (PhD) is brought to you for free and open access by the
Graduate School of Biomedical Sciences at DigitalCommons@The Texas
Medical Center. It has been accepted for inclusion in UT GSBS
Dissertations and Theses (Open Access) by an authorized administrator of
DigitalCommons@The Texas Medical Center. For more information,
please contact laurel.sanders@library.tmc.edu.
Recommended Citation
Castillo, Eliseo F., "Defining the role of IL-15 trans-presentation by distinct cell-types during the development and homeostasis of
Natural Killer and invariant Natural Killer T cells" (2010). UT GSBS Dissertations and Theses (Open Access). Paper 59.
DEFINING THE ROLE OF IL-15 TRANS-PRESENTATION BY DISTINCT 
CELL-TYPES DURING THE DEVELOPMENT AND HOMEOSTASIS OF 
NATURAL KILLER AND INVARIANT NATURAL KILLER T CELLS 
 
By 
Eliseo Fernando Castillo, B.S., M.S.  
 
 
APPROVED: 
 
 
 
______________________________ 
Kimberly S. Schluns, Ph.D., Supervisory Professor 
 
 
 
______________________________ 
Dean A. Lee, M.D., Ph.D. 
 
 
 
______________________________ 
Nancy J. Poindexter, Ph.D. 
 
 
 
______________________________ 
Stephen E. Ullrich, Ph.D. 
 
 
 
______________________________ 
Dapeng Zhou, M.D., Ph.D. 
 
 
APPROVED: 
 
 
____________________________ 
George M. Stancel, Ph.D. 
Dean, The University of Texas 
Graduate School of Biomedical Sciences at Houston 
 ii 
DEFINING THE ROLE OF IL-15 TRANS-PRESENTATION BY DISTINCT  
CELL-TYPES DURING THE DEVELOPMENT AND HOMEOSTASIS OF  
NATURAL KILLER AND INVARIANT NATURAL KILLER T CELLS 
 
 
A 
 
 
DISSERTATION 
 
 
Presented to the Faculty of  
The University of Texas 
Health Science Center at Houston 
and  
The University of Texas 
M.D. Anderson Cancer Center 
Graduate School of Biomedical Sciences 
In Partial Fulfillment 
 
 
Of the Requirements 
 
 
for the Degree of 
 
 
DOCTOR OF PHILOSOPHY 
 
 
By  
 
 
Eliseo Fernando Castillo, B.S., M.S. 
 
 
Houston, Texas 
 
 
August, 2010 
 
 
 
 iii 
 
 
 
 
 
 
 
 
 
To Celestee, Tristan, Dylan and Sofie 
Making the impossible – Possible! 
 
 
 
 
 
 
 
 
 
 
 iv 
ACKNOWELDGEMENTS 
 
I would first like to thank God for all the blessings in my life – Celestee, Tristan, 
Dylan, and Sofie. Your love, support and laughter gives me the inspiration to be the 
best I can be. I would also like to thank my father and mother as well as my brothers 
and sisters whose love and support has been instrumental in all my life 
accomplishments.  
 
I would like to express my sincere gratitude to my mentor, Dr. Schluns, your advice, 
guidance, patience and understanding over the years has been very influential in 
my success and development into a scientist.  Thank you for giving me the most 
promising projects in the lab! I would also like to extend my thankfulness to the 
members of my supervisory committee, Drs. Dean Lee, Nancy Poindexter, Stephen 
Ullrich and Dapeng Zhou, for their support and guidance in my Ph.D. training. 
 
Finally, I would like to thank all the past and present members of the Schluns’ Lab 
and all the members of the Immunology department. Your support and friendship 
has provided and enjoyable learning environment. Thank you. 
 
 v 
DEFINING THE ROLE OF IL-15 TRANS-PRESENTATION BY DISTINCT  
CELL-TYPES DURING THE DEVELOPMENT AND HOMEOSTASIS OF 
NATURAL KILLER AND INVARIANT NATURAL KILLER T CELLS 
Publication No. ______ 
Eliseo F. Castillo, B.S., M.S. 
Supervisory Professor: Kimberly S. Schluns, Ph.D. 
The immuno-regulatory functions displayed by NK and iNKT cells have highlighted 
their importance as key lymphocytes involved in innate and adaptive immunity. 
Therefore, understanding the dynamics influencing the generation of NK and iNKT 
cells is extremely important. IL-15 has been shown to provide a critical signal 
throughout the development and homeostasis of NK and iNKT cells; however, the 
cellular source of IL-15 has remained unclear. In this investigation, I provide 
evidence that the cell-type providing IL-15 to NK and iNKT cells via trans-
presentation is determined by the tissue site and the maturation status of NK and 
iNKT cells. For NK cells, I revealed the non-hematopoietic compartment provides 
IL-15 to NK cells in the early stages of development while hematopoietic cells were 
crucial for the generation and maintenance of mature NK cells. Regarding iNKT 
cells in the thymus, IL-15 trans-presentation by non-hematopoietic cells was crucial 
for the survival of mature iNKT cells. In the liver, both hematopoietic and non-
hematopoietic compartments provided IL-15 to both immature and mature iNKT 
cells. This IL-15 signal helped mediate the survival and proliferation of both NK and 
iNKT cells as well as induce the functional maturation of mature iNKT cells via 
enhanced T-bet expression. In conclusion, my work illustrates an important notion 
that the immunological niche of NK and iNKT cells is tightly regulated and that this 
regulation is meticulously influenced by the tissue microenvironment. 
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CHAPTER 1 
 
REVIEW OF RELAVANT LITERATURE 
 
1.1 Cytokine Biology. 
Multiple modes of cellular communication exist between various cells of the immune 
system and a class of proteins referred to as cytokines are fundamental in this 
process. Receiving cytokine-induced messages can result in multiple outcomes 
including: cellular growth, survival, differentiation or activation. To receive this 
message the cell must express the cytokines specific receptor(s) and the 
downstream receptor signaling subunits. Cytokines and their receptors are grouped 
into specific families based on protein structure. Individual cytokines use distinct 
receptors for signaling specificity and are usually paired with an additional mutual 
family receptor subunit. One family of cytokines crucial for the generation and 
maintenance of cells from both the innate and adaptive immune system are the 
cytokines that share the common γ chain (γC) receptor 1. The γC family cytokine 
members include Interleukin-2 (IL-2), IL-4, IL-7, IL-9, IL-15 and IL-21.  
 
Interestingly, a mutation in the γC subunit has been attributed to one of the most 
common and most severe immunodeficiency in humans, X-linked severe combined 
immunodeficiency (X-SCID) 2,3. Highly publicized and given the moniker “Bubble 
boy disease”, X-SCID results in the failure to develop both T and NK cells, and have 
functionally impaired B cells in humans; while X-SCID mice have a major defect in 
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T, B and NK cells 2-5. Given that the γC subunit was identified as one of the 
receptors for IL-2 6 and a deficiency in IL-2 7-9 did not match the X-SCID phenotype 
suggested the γC subunit was crucial for the function of other cytokines involved in 
T, B and NK cell development and function. As such, IL-4, IL-7, IL-9, IL-15 and IL-
21 were identified as the other cytokines utilizing the γC subunit 3. The generation of 
gene-targeted knockout mice revealed both IL-7 (and IL-7Rα) and IL-15 were the 
actual cytokines that attributed to the X-SCID phenotype 10-13. Thus, understanding 
how γC cytokines and their respective receptors function is essential in the 
understanding the factors that generate a functional immune system. 
 
1.2 The Biology of IL-15. 
1.2.1 IL-15 and IL-15 receptors. 
IL-15 is a member of the four α-helix bundle cytokine family 14,15.  First described as 
a growth factor for T cells with similar function to IL-2, IL-15 has since been shown 
to mediate diverse biological functions on various immune cells 16. Furthermore, the 
expression pattern and regulation of IL-2 and IL-15 are quite different from one 
another. IL-2 is produced mainly by activated CD4+ T and CD8+ T cells through 
TCR and CD28 stimulation and regulated at the level of mRNA transcription and 
stabilization 17,18. Opposite to IL-2, IL-15 mRNA is constitutively expressed at 
steady-state in multiple cell-types ranging from both hematopoietic (e.g. DCs and 
monocytes/macrophages) and non-hematopoietic (e.g. fibroblast and epithelial 
cells) origin. Furthermore, IL-15 mRNA can be enhanced by IFN-γ and LPS or upon 
viral or bacterial stimulation (in DCs and macrophages) 16,19,20. Nevertheless, the 
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production IL-15 does not always correlate with mRNA expression and is in fact 
regulated at multiple levels starting from transcription, translation, intracellular 
trafficking and secretion 16,20. Lastly, the receptors of IL-15 are also critical for the 
secretion of IL-15 (discussed below) 20. Thus, IL-2 and IL-15 perform their function 
and are expressed under different physiological and immunological conditions. 
  
IL-15 is produced by IL-15 utilizes three receptors consisting of the unique IL-15Rα, 
the shared IL-2/15Rβ and the common γC subunits 16. The IL-15Rβ/γ subunits are 
the major signal transducer for IL-15 activating the Janus kinase (Jak) and signal 
transducer and activator of transcription (STAT) pathway. In lymphocytes, IL-15Rβ 
is coupled to Jak1 and STAT3 activation while the γC associates with Jak3 and 
STAT5 16. IL-15 signaling also triggers other pathways involved in PI3 kinase/AKT, 
NF-κB, Bcl-2, c-myc and fos/jun activation 16. Regarding IL-15Rα, lymphocytes 
appear not to signal through this receptor subunit.   
 
IL-15 shares the IL-15Rβ/γ subunits with IL-2 and like IL-15, IL-2 also has its own 
distinct receptor, IL-2Rα. Unlike IL-2 and IL-2Rα, IL-15 and IL-15Rα mRNA is 
expressed in cells of both hematopoietic and non-hematopoietic origin 16. Although 
IL-15 and IL-15Rα is widely expressed by diverse cells throughout the body it 
explicitly affects cells of the innate and adaptive immune system. In particular, a 
deficiency in this cytokine or its specific receptor, IL-15Rα, results in a significant 
loss of natural killer (NK), invariant NKT (iNKT), memory CD8+ T cells and intestinal 
intraepithelial lymphocytes (iIEL) 13,21. In complete contrast, over-expression of IL-
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15 in mice leads to the massive expansion of NK and memory CD8+ T cells and 
consequently develops fatal lymphocytic leukemia 22.  Therefore, IL-15 signaling 
must be tightly regulated and distributed conservatively to generate a competent 
immune system and prevent terminal pathological conditions. 
 
1.2.2 Trans-presentation of IL-15. 
The striking similarities between IL-15- and IL-15Rα-deficient mice were unusual 
given that IL-15Rα has no role in IL-15 signaling. But this similarity suggested an 
important role for IL-15Rα in IL-15 signaling.  Unlike conventional cytokines utilizing 
heterodimeric or –trimeric receptor subunits, IL-15 is thought to work through a 
unique mechanism of delivery termed “trans-presentation” (depicted in FIGURE 1) 
23-25
. Trans-presentation involves two cell-types, an IL-15 producing cell (e.g. 
hematopoietic or non-hematopoietic origin) and an IL-15 responsive cell for this 
method of cytokine delivery. Specifically, the IL-15 producing cell produces both IL-
15 and IL-15Rα then shuttles them as a complex to the cell surface to stimulate a 
neighboring IL-15 responsive cell expressing IL-15Rβ/γC subunits.  
 
Evidence for this novel mechanism of cytokine delivery was derived from both in 
vitro and in vivo studies. The first suggestion IL-15 was delivered in “trans” was the 
identification of surface-bound IL-15 on monocytes which stimulated adjacent T 
cells in vitro 19. It was further revealed IL-15Rα was associated with cell surface IL-
15 and this cell surface IL-15 was biologically active 19,26. Additional evidence 
supporting the trans-presentation model came when IL-15Rα-/- CD8+ T cells  
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FIGURE 1. Trans-presentation of IL-15. 
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FIGURE 1. Trans-presentation of IL-15. 
Cartoon representing the receptors utilized during IL-15 trans-presentation. The 
trans-presenting cell (source) must express both IL-15 and the specific IL-15Rα 
subunit. Both hematopoietic and non-hematopoietic cells can be the source of IL-
15. In order to respond to IL-15, the IL-15-dependent cell (target) must express 
both IL-15Rβ and γc subunits in addition to the appropriate intracellular signaling 
components. 
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responded to plate-bound IL-15/IL-15Rα 27. Further studies corroborated these in 
vitro data revealing IL-15Rα expression by memory CD8+ T cells and other IL-15 
responsive cells (i.e. iIELs and NK cells) is not required to respond to IL-15 in vivo 
28-31
. Transfer experiments further revealed that IL-15Rβ/γC expression is required 
by NK cells while IL-15Rα expression by the host was crucial for in vivo functions of 
IL-15 32. Finally, several studies revealed the same cell producing IL-15 must 
express IL-15Rα to deliver IL-15 20,28,33. Overall, both in vitro and in vivo studies 
supported this mode of cytokine delivery by revealing a) IL-15 and IL-15Rα are 
produced by the same cell to stimulate adjacent cells; b) IL-15Rα expression is not 
required by the responding cell; and c) the responding cell must express the IL-
15Rβ/γ chain subunits.  
 
These prior studies revealed the basic requirements to receive and respond to IL-
15. Because IL-15 and IL-15Rα are ubiquitously expressed, it suggests multiple 
cell-types trans-present IL-15 to NK, iNKT, iIELs and memory CD8+ T cells. Despite 
the fact that IL-15 is expressed by multiple sources, it is tightly regulated and 
competition for IL-15 exist between these responding cells 16,34. These two basic 
factors, tight regulation and competition for IL-15, perhaps shape the IL-15 niche for 
NK, iNKT, iIELs and memory CD8+ T cells. Since these cells occupy similar 
anatomical locations, acquiring IL-15 from different sources in these various 
microenvironments would ensure the generation and maintenance of each 
population.  
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Indeed, preferences in cell-specific IL-15 trans-presentation by hematopoietic or 
non-hematopoietic cells have been shown for memory CD8+ T cells and intestinal 
intraepithelial lymphocytes, respectively 28-30. This cell specificity in IL-15 trans-
presentation was not observed for NK and NK1.1+ T cells as both cellular 
compartments could partially generate both populations 29. Recently, we have 
identified dendritic cells (DC) as one of the main hematopoietic cell-types that 
support the homeostatic proliferation of memory CD8+ T cells via IL-15 trans-
presentation 35. For iIELs, we found the expression of IL-15Rα solely by intestinal 
epithelial cells induces the proliferation and survival of iIELs to recovery this 
population deficient in the IL-15Rα-/- model 36. Once again, these studies highlight 
the fact IL-15Rα expression by IL-15-dependent cells is unnecessary but absolutely 
required on cells in the microenvironment they occupy. Thus, recognizing the cells 
that trans-present IL-15 will help identify the cellular targets that can directly 
augment specific IL-15-dependent populations. Despite much progress being made 
in identifying the trans-presenting cell for memory CD8+ T cells and iIELs, the 
specific cell-type(s) trans-presenting IL-15 to NK and iNKT cells is unclear and the 
function being mediated by IL-15 is also uncertain. Therefore, I have investigated 
what cellular compartments trans-present IL-15 to NK and iNKT cells. Additionally, I 
have also identified the tissue-specific functions of IL-15 for NK and iNKT cells 
(discussed in Chapter 2 and 3, respectively). 
  
1.3 Natural Killer Cells. 
1.3.1 NK cells and their function. 
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First acknowledged as large granular lymphocytes lacking T and B cell markers, NK 
cells are now recognized as a critical component of the innate immune system. 
Unlike the adaptive immune cells, these innate cells respond rapidly to detect and 
eliminate virus-infected or transformed cells. The name “natural killer” is derived 
from the initial observation that NK cells could kill tumor cells without prior 
activation. In more recent years, it has now been accepted these lymphocytes are 
more than just “natural killers”. In addition to cytolytic activity, NK cells can also 
release immuno-regulatory cytokines that affect cells from both innate and adaptive 
immune systems (FIGURE 2). These innate lymphocytes are hematopoietic-derived 
and develop in the bone marrow microenvironment but also occupy other peripheral 
tissues. In mice, NK cells make up about 0.5 – 1% of the lymphocyte population in 
the BM, 15-25% in the liver, 1-5% in the spleen, and 10-20% of the lymphocytes in 
the blood 37.  
These BM-derived innate lymphocytes can act as the first detector and responder in 
certain immune challenges. NK cells can kill target cells via the granzyme b/perforin 
exocytosis pathway or by using TRAIL- and FasL-mediated pathways. They can 
also release cytokines such as IFN-γ and TNF-α and chemokines like CCL3, CCL4 
and CCL5 to enhance the immune response 38. This production of cytokines and 
chemokines can consequently recruit, activate and induce the maturation of DCs, 
macrophages and CD8+ T cells. NK cells may also limit the immune response by 
killing immature DCs and activated CD4+ T cells 38. These functional attributes 
depend heavily on a barrage of germ-line encoded NK cell surface receptors  
 10 
FIGURE 2. NK cell immune regulation. 
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FIGURE 2. NK cell immune regulation. 
Cartoon illustrating the functional plasticity of NK cells.  Detection of transformed- or 
viral-infected cells or cytokine stimulation results in NK cell activation and 
subsequent death of the target cell. Activated NK cells can produce various 
cytokines including IFN-γ which can trigger an immune response by inducing the 
maturation of DCs and macrophages as well as activating CD8+ T cells. Activated 
NK cells can also limit the immune response by killing immature DCs. Thus, NK 
cells are a fundamental part of the immune response linking both innate and 
adaptive arms of the immune system. 
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(TABLE 2) and various other extracellular cues (IL-2, IL-12, IL-15, IL-18 and type I 
IFNs) that induce or enhance their functional capabilities 37,39. 
 
Although first believed to possess the ability to spontaneously kill without prior 
activation or sensitization, NK cell function is a developmentally acquired process 
dependent on the strength of receptor stimulation and cytokine responsiveness 39. 
The germ-line encoded receptors responsible for NK cell function are acquired 
during development and function as either an activating or inhibitory stimulus. In 
mice, the stimulatory balance is dictated by the heterogeneous expression of a 
variety of receptors that include the CD94/NKG2 family heterodimers, 2B4, Ly49 
family members and other c-lectin molecules such as NKG2D, NK1.1, NKp46, NKR-
P1B, NKR-P1A and KLRG1. The ligands for the activating receptors can be induced 
by cellular stress, DNA damage or infection as is the case for NKG2D ligands 
RAE1, H60 and MULT1 in mice or encoded by the viral pathogen m157 (i.e. Ly49H 
ligand) expressed by Murine Cytomegalovirus (MCMV) 40-42. The ligands for the 
various inhibitory receptors include MHC class Ia molecules and other self-ligands 
that dampen or inhibit the activating signals received by various activating NK cell 
receptors. This response can be lost due to recognition of decreased or complete 
loss of inhibitory ligands (also known as “missing self”) and the induction and 
recognition of activating ligands 43. Consequently, this expression and detection 
system allows NK cells to be equipped and enabled to recognize healthy versus 
diseased cells, a process known as NK cell “education”. 
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TABLE 1. NK cell receptors. 
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TABLE 1. NK cell receptors. 
A brief list of murine NK cell activating and inhibitory receptors and the known 
ligands they interact with is displayed. The receptors are listed in the order each are 
acquired during development with early immature and late immature being 
distinguished by Ly49 expression, and late mature is a population of NK cells 
expressing high levels of CD11b. The stages of NK cell development is shown in 
FIGURE 3.
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Unlike T and B cell education that involves a selection process, NK cell education 
(also referred to as “licensing” or “disarming”) is a developmental process that 
generates functionally mature albeit self-tolerant NK cells 44,45. NK cell education is 
achieved upon interactions between NK MHC class I inhibitory receptors (Ly49) and 
corresponding classical MHC class Ia ligands 46. These inhibitory receptors set the 
threshold for NK cells responses to target cells under cellular stress or pathogenic 
invasion. Without this form of instruction, NK cells do not respond to stress- or 
pathogen-induced activating ligands 44,45. Hence, NK cell education grants NK cells 
the ability to become functionally responsive to activating signals and “missing self”. 
There are situations where both activating and inhibitory ligands are present on the 
target cell. But under this scenario the balance is geared to either activation status 
or inhibition based on the strength of the stimulatory signal. Thus, the acquisition of 
these inhibitory Ly49 molecules and subsequent “education” is crucial for the 
function of NK cells.  Nevertheless, the stage of development where NK cell 
“education” occurs is unclear and it is thought to require an additional unknown 
activating signal 33,46.  
1.3.2 NK cell development and homeostasis. 
Multiple groups have investigated the lineage commitment of hematopoietic stem 
cells into NK cells. This commitment to a specific lymphocyte population involves 
the transition through several developmental stages for functional maturation 47,48. 
These events are regulated by various transcription factors and cytokines which 
dictate the changes in cellular phenotype and function 37. Until recently, it was 
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thought that all murine NK cells develop in the BM; however, recent reports have 
shown a population of NK cells that develop in the thymus 49. Below I will give a 
brief overview of NK cell differentiation, and the transcription factors and cytokines 
involved in the commitment and development of BM-derived NK cells. 
The earliest stage of NK cell commitment is the transition of common lymphoid 
progenitors (CLP) that are defined as Lineage- IL-7Rα+ Thy-1- Sca-1Low c-KitLow 
to NK precursors (NKp) 30. NKp’s express IL-15Rβ (CD122) and are completely 
negative for other known NK cell markers, such as NKR-P1C (NK1.1, expressed in 
C57BL/6 mice) and the various activating and inhibitory receptors 47,48. Transition 
from NKp to immature NK cells is marked by the expression of NKG2D, NK1.1 and 
the CD94/NKG2 heterodimeric complex. This is followed by the stochastic 
expression of various activating and inhibitory Ly49 receptors; however, these cells 
are still considered immature 47. The conversion from immature to mature NK cell is 
distinguished by the expression of CD49b (DX5) and by the capacity to kill and 
produce pro-inflammatory cytokines 50. These functional attributes are enhanced 
with the up-regulation of CD11b and CD43 47. Recently, the expression CD27 and 
CD11b have also been used to discern immature and mature NK cell 51; however, 
the differentiation events stringently described above are depicted in FIGURE 3. 
 
During the life span of NK cells, from NK commitment to functional maturation, 
multiple transcription factors are expressed in a developmental manner (discussed 
below). Furthermore, NK cells continuously express CD122 throughout 
development and inevitably depend on the cytokine, IL-15, for their generation and  
 17 
FIGURE 3. NK cell development. 
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FIGURE 3. NK cell development. 
Detailed illustration of BM-derived NK cell differentiation. NK precursors (NKp), 
stage 1, are the first noted population committed to the NK cell lineage displaying a 
CD122+ lineage-negative phenotype. NKp’s then differentiate into immature NK 
cells and acquire various NK cell receptors (Bold font) as maturation proceeds. 
This immature population is further broken down into early (stage II) and late (stage 
III) immature NK cells and is distinguished from each other by the acquisition of the 
Ly49 repertoire. DX5 expression marks the transition into mature NK cells and is 
accompanied by effector function. Mature NK cells gain enhanced functional 
attributes as terminal maturation proceeds and this event is demarcated by the up-
regulation of CD11b. Additionally, various transcription factors that are involved in 
the NK cell commitment and development are also depicted in this figure.  
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maintenance (discussed in the next section). Within this differentiation process, 
there exist other developmental events such as NK cell education (self versus non-
self recognition), proliferation and survival that have yet to be definitively resolved.  
 
In the BM, CLPs can give rise to either B cells or NK cells. The commitment to one 
population over the other appears to be dependent on the E protein transcription 
factors, E2A; inhibitors of E protein transcription factors, Id2 and Id3; and EBF1 (Id2 
and Id3 antagonist) 52,53. E2A regulates the expression of Id2, Id3 and EBF1. 
Accordingly, if EBF1 inhibits Id2 and Id3, CLPs will become committed to the B cell 
lineage. Conversely, if Id2 and Id3 can inhibit E2A expression and subsequently, 
EBF1 expression, CLPs will become committed to the NK cell lineage. What 
dictates one fate over the other is currently unknown but is thought to be 
determined by the excess of transcriptional activity and the levels of each these 
transcription factors expressed 52. Interestingly, the inhibition of E2A does not 
reduce the expression of Id2 and Id3. In fact, Id2 mRNA increases as cells become 
more restricted to the NK lineage and lineage commitment is noted by the up-
regulation of CD122, which Id2 has been shown to regulate 53. Mice deficient for Id2 
lack immature and mature NK cells but not NK precursors 53. This discrepancy in 
NK cell commitment may be because of other transcription factors regulating 
CD122 expression. In Id2-/- mice, Id3 is still expressed and may be compensating 
for the loss of Id2. Ikaros and Runx3 have also been shown to regulate CD122 
expression 54,55. Perhaps this redundancy is to ensure the commitment of CLPs into 
NKps. 
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Once committed to the NK cell lineage, multiple transcription factors are involved in 
the maintenance and functional maturation of NK cells. It has recently been shown 
mice deficient in E4bp4, a bZIP transcription factor have a specific defect in 
immature and mature NK cells 56,57. E4bp4-/- NK cells also display a defect in 
cytolytic activity and cytokine production. Moreover, E4bp4 was shown to regulate 
Id2 expression but these mice do retain NKp 56. So E4bp4 likely assists in the 
differentiation of NKp to immature NK cells. The transition of immature NK cells to 
mature NK cells appears to involve multiple transcription factors that may act in 
successive manner. 
 
The generation of mature peripheral NK cells appears to be dependent on Gata-3, 
T-bet, and IRF-2. Mice deficient in Gata-3-/- have a selective loss of mature hepatic 
NK cells, reduced Ly49, IFN-γ and T-bet expression 58. T-bet-/- mice have a severe 
reduction in all peripheral mature NK cells while IRF-2 affects mature splenic NK 
cells and NK cell cytotoxicity 59,60. This defect in function in Gata-3 and IRF-2 
deficient mice may be indirect since other transcription factors, such as MEF and 
CEBP-γ 61,62, contribute to NK cell cytotoxicity and cytokine production but have no 
role in NK cell numbers or maturation. It could be speculated that E4bp4 regulates 
Gata-3 which in turn regulate T-bet and IRF-2. These two latter molecules may 
regulate MEF or CEBP-γ to control NK cell function. Undoubtedly, other 
transcription factors may contribute to the generation and functional maturation of 
NK cells but the overall molecular events that are involved appear to be 
developmentally and sequentially regulated. Therefore, understanding how these 
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molecular events occur will provide an understanding of why and how this 
heterogeneous lymphocyte population exist and functions. 
 
1.3.3 The role of IL-15 in NK cell biology. 
The acquisition of IL-15Rβ in the early phase of NK cell development highlights the 
critical role for IL-15 during the developmental life span of this population. The 
absence of IL-15 or any of its receptor subunits results in a deficiency of NK cells, 
which highlights the importance of IL-15 in the overall generation of NK cells 5,13,21,63. 
Since trans-presentation is established as a major mechanism of IL-15 delivery, 
then identifying the "trans-presenting" cell type(s) will enhance our understanding of 
how IL-15 responses are regulated during NK cell development. 
Because radiation-resistant BM stromal cells express IL-15 transcripts, it has long 
been suggested these cells are a major cell type providing IL-15 to developing NK 
cells 64-66. More recently, the utilization of IL-15Rα BM chimeras revealed IL-15 and 
IL-15Rα+ expression by hematopoietic cells rather than non-hematopoietic cells 
appeared to be a more vital source of IL-15 during the generation of NK cells 29; 
however, both cell types can partially support some NK cell development. More 
specifically, IL-15Rα expression by hematopoietic cells has also been shown to 
regulate Ly49 expression on NK cells thereby implementing IL-15 in the 
differentiation process 67. Although it was suggested IL-15Rα expression specifically 
by NK cells affects Ly49 expression 67, these data still support a role for IL-15 in the 
acquisition of the Ly49 repertoire.  
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In addition to its role in differentiation, IL-15Rα expression by hematopoietic cells 
also plays a major role in the homeostatic maintenance of mature NK cells 28,31. 
Such maintenance is mediated by IL-15-driven expression of anti-apoptotic 
molecules Bcl-2 and Mcl-1 and the down-regulation of proapoptotic molecules, Bim 
and Noxa 32,68-72. While IL-15Rα expression by NK cells appeared to be critical for 
Ly49 expression, IL-15Rα expression by NK cells is not required for its homeostatic 
proliferation or survival 67. Hence, IL-15 trans-presentation emerges as the major 
mode of action during homeostasis 28,31,32,67. Finally, IL-15 trans-presentation, 
specifically by dendritic cells (DC) activates NK cells during an immune response to 
viruses or bacteria 73. Thus, IL-15 is critical in all aspects of NK cell biology from 
development to functional maturation to activation.  
Overall, these findings suggest that different cell compartments may have distinct 
roles in NK cell development. So now the initiative must be made to distinguish 
which hematopoietic and non-hematopoietic cells drive NK cell development and 
homeostasis through IL-15 trans-presentation. Whether DCs can also trans-present 
IL-15 during the development and homeostasis of NK cells is unclear.  DCs express 
both IL-15 and IL-15Rα and can interact with NK cells in vivo 20,74,75. Thus, DCs may 
likely be one of the major hematopoietic cell-types providing IL-15 to NK cells during 
development and maintenance 76. Furthermore, since developmental intermediates 
are found in the spleen and liver, it is possible that the cell-type trans-presenting IL-
15 is tissue site specific and/or stage specific. 
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1.4 Invariant Natural Killer T Cells. 
1.4.1 iNKT cells and their function. 
Murine NKT cells are a population of T cells that are dependent and selected by 
CD1d, a MHC class I-like molecule that presents glycolipid antigen 77-80. Within this 
CD1d-dependent population of lymphocytes there exist two types of NKT cells that 
are classified on the basis of T cell receptor (TCR) usage. Type I NKT cells express 
an invariant TCR Vα14-Jα18 α chain coupled with either Vβ8, Vβ7 or Vβ2 β chain 
(Vα24-Jα18/Vβ11 in humans) and are also referred to as invariant NKT (iNKT) cells 
81-83
. iNKT cells are reactive to the glycolipid, α-Galactosylceramide (αGalCer) and 
also recognize the self-ligand isoglobotrihexosylceramide 84,85. This recognition of 
αGalCer allows iNKT cells to be detected by αGalCer-loaded CD1d-tetramers 86,87. 
Unlike iNKT cells, type II NKT cells express a diverse repertoire of TCR α chains 
and are also non-reactive to αGalCer thus undetectable by CD1d-tetramers 88. 
Herein, I will discuss what is known and unknown about iNKT cell biology. 
 
In addition to the invariant TCR, iNKT cells express multiple cell surface receptors 
associated with NK cells. Consequently, they were given the moniker “natural killer” 
T cells; however, not all iNKT cells express NK cell receptors (discussed in the next 
section). But similar to NK cells, iNKT cells are functionally active immediately upon 
stimulation and thus behave in an innate-like fashion 89. One innate attribute is the 
ability to activate cells from both the innate and adaptive immune system (FIGURE 
4). This immune regulation is because iNKT cells can produce multiple cytokines 
such as IL-4, IFN-γ and IL-17 which are usually restricted to specific  
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FIGURE 4. iNKT cell immune regulation. 
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FIGURE 4. iNKT cell immune regulation. 
Cartoon illustrating the immuno-regulatory properties of iNKT cells. Activation of 
iNKT cells can induce the production of both Th1 (IFN-γ) and Th2 (IL-4) cytokines 
by iNKT cells. The production of IFN-γ by iNKT cells can activate both NK and 
CD8+ T cells and can also induce the maturation of DCs. The Th2 cytokines being 
produced by iNKT cells has been shown to stimulate the differentiation of 
monocytes into DCs as well as mount a humoral immune response. Thus, the 
activation of iNKT cells and subsequent cytokines they produce can be the 
determining factors in dictating the outcome of the immune response. 
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subsets of conventional CD4+ T cells 90-92. Consequently, the ability to rapidly 
produce multiple cytokines can dictate the immune response and subsequent 
outcome.  
 
While iNKT cells are known to produce multiple cytokines it is now appreciated that 
multiple factors contribute to the cytokines being produced. One such factor is that 
subsets of iNKT cells exist in both mice (CD4+ and CD4-CD8- also called double 
negative [DN] subsets) and humans (CD8+, CD4+ and DN subsets). In humans and 
in some cases in mice, certain iNKT subsets can favor a Th2 cytokine profile (CD4+ 
iNKT cells) while other subsets display a Th1 or Th17 cytokine profile (DN iNKT 
cells) 90,92-94. In addition, the strength of TCR stimulation can affect IL-4 versus IFN-
γ production.  Whereas a quick TCR stimulation induces more IL-4, a longer 
interaction between CD1d-TCR invokes a strong IFN-γ response 95,96. Other factors 
influencing the cytokine production include the glycolipid activating iNKT cells. The 
glycolipid, αGalCer, is known to induce some IL-4 and copious amounts of IFN-γ. 
OCH, a modified form of αGalCer, invokes a remarkably different response by 
inducing more IL-4 and lower amounts of IFN-γ 97-99. Hence, the cytokine(s) 
production by activated iNKT cells is a dynamic event which can determine the 
immune response. Therefore, understanding all the factors contributing to the 
function of iNKT cells is essential and exploitable knowledge. 
 
Interestingly, the immuno-regulatory activity of iNKT cells includes a protective role 
in various autoimmune diseases and a pathogenic role in various inflammatory 
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diseases 100,101. This protective and pathogenic role of iNKT cells is also observed 
in various tumor models. For instance, several independent studies have shown 
iNKT cells can enhance or suppress an anti-tumor response 102-104. Initially, murine 
iNKT cells were shown to have anti-tumor function by rejecting tumors and 
preventing tumor metastasis 105,106. These effects were mediated by iNKT cell 
production of IFN-γ and subsequent activation of DCs, NK, B and CD8+ T cells. 
Conversely, the production of IL-4 and IL-13 by iNKT cells contribute to the 
suppressive activity observed in various murine tumor models 102,104. Taken 
together, these studies reveal iNKT activation can be either beneficial or detrimental 
to the host depending on the antigen or subset of cells being activated. The basis of 
these paradoxical features appears to depend on either the tissue site in which the 
iNKT subset is isolated or perhaps developmental signals they receive in these 
tissue microenvironments. For these reasons, understanding the events that 
regulate the development of iNKT cells is essential for host immunity and possible 
clinical exploitation. 
 
1.4.2 iNKT cell development and homeostasis.  
Similar to conventional T cells, iNKT cell are derived from the same hematopoietic 
precursor where they also develop in the thymus making up ~0.5 - 1% of all 
lymphocytes residing in the thymus 89. Additionally, iNKT cells like conventional T 
cells are also found in the periphery where they represent approximately 2% of all 
lymphocytes in the spleen and up to ~20 - 30% of the lymphocytes in the liver 89. 
However, the developmental process of iNKT cells does not follow the conventional 
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T cell pathway 79,90,107.  Developing iNKT cells go through multiple transitional 
stages that can be followed by staining with CD1d-tetramers along with other cell 
surface markers (such as CD4, CD44, and NK1.1) 86,87 (FIGURE 5).  
 
The earliest detectable stage of iNKT cell development occurs after Vα14-Jα18 
rearrangement and positive selection by CD1d+ double positive ( CD4+CD8+, DP) 
thymocytes 80. This population is detectable by CD1d-tetramers and exhibits a CD4+ 
CD44Low NK1.1-  cellular phenotype 86,90. As previously mentioned, DN iNKT 
subsets also exist in mice but the stage where CD4 is down-regulated giving rise to 
the DN population is currently an ambiguous developmental event. Despite being 
immature, CD4+ CD44Low NK1.1- iNKT cells are capable of producing IL-4 when 
stimulated in vitro 90,107. These immature iNKT cells expand and differentiate into 
CD44High cells which are capable of producing both IL-4 and a small amount IFN-
γ (in vitro stimulation) and exiting the thymus to seed the periphery 90,107. Although 
thymic iNKT cell emigration occurs at this stage, a portion of iNKT cells begin to up-
regulate the chemokine receptor, CXCR3, which assists in the retention of thymic 
iNKT cells 108. The final stage of development or maturation is demarcated by 
NK1.1 and CD122 expression and is accompanied by further expansion 59,90.  
Unlike their predecessors, mature iNKT cells produce more IFN-γ when activated in 
vitro, but retain some ability to produce IL-4 90.  Again, atypical of normal 
conventional T cell development, this final stage of maturation of iNKT cells can 
occur either in the thymus or the periphery.  
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FIGURE 5. iNKT cell development. 
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FIGURE 5. iNKT cell development. 
Detailed illustration of iNKT cell differentiation occurring in the thymus and 
periphery. The first stage of development is an immature cell bearing 
CD44LowNK1.1- cell surface phenotype and is capable of producing IL-4.  This 
immature population can expand and differentiate into a population expressing 
CD44HighNK1.1- phenotype. At this stage this population is still capable of producing 
IL-4 and can emigrate from the thymus to seed the periphery. In the thymus and 
periphery, iNKT cells displaying CD44HighNK1.1- cell surface markers can expand 
and differentiate into a population also expressing NK1.1+, which has previously 
been described as a mature population of iNKT cells. This population of iNKT cells 
is geared more towards producing IFN-γ but is still capable of producing IL-4. In 
addition to cell surface receptors acquired throughout development, various 
transcription factors that are involved in iNKT cell commitment and development are 
also depicted in this figure. 
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While maturation of iNKT cells is usually defined by the acquisition of NK1.1 
expression, functional maturation does not always correlate with NK1.1 expression.  
Despite the expression of NK1.1, thymic iNKT cells in normal mice do not express 
IFN-γ in response to αGalCer 87 suggesting these cells are suppressed, or not 
inadequately stimulated in the thymus, or perhaps not truly functionally mature. 
Moreover, it has recently been suggested that the NK1.1- iNKT cells in the periphery 
may be mature or possibly a subset of iNKT cells that only transiently expresses 
NK1.1 109. Therefore, functional responsiveness, or true maturation of iNKT cells is 
not inherent to all NK1.1+ iNKT cells and therefore is likely subject to additional 
regulation. Regardless of the phenotype or state of functional maturation, peripheral 
iNKT cells are maintained in the periphery by prosurvival factors, Bcl-xL and Bcl-2, 
and undergo slow homeostatic proliferation 110. Such maintenance is dependent on 
IL-15 (discussed in the next section) and independent of CD1d-TCR interaction 
34,111
. However, the cell-type providing IL-15 during peripheral homeostasis is 
currently unknown. 
 
Throughout iNKT cell development, a transcriptional network exists that allows for 
the generation, differentiation and functional maturation of iNKT cells. At the earliest 
point of iNKT cell development various transcription factors are critical in the 
commitment to the iNKT lineage by regulating TCR rearrangement. For example, a 
complete loss of iNKT cells is apparent in mice deficient in HEB (E protein 
transcription factor), RORγt and the Runx1 (Runx family member) 91,112,113. The 
complete loss of iNKT cells in HEB-/- and RORyt-/- mice is due to the lack of Vα14-
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Jα18 rearrangement; however, Vα14-Jα18 rearrangement does occur in Runx1-/- 
mice 112,113. This suggests HEB and RORγt act upstream of Runx1 to generate the 
invariant TCR while Runx1 is critical either during or immediately after positive 
selection by CD1d+ DP thymocytes. Additionally, RORγt expression appears to be 
critical for IL-17 production by iNKT cells, revealing multiple steps of developmental 
regulation being carried out by various transcriptional factors 91. 
 
Once iNKT cells are selected, the CD4+ CD44Low NK1.1- iNKT cells begin to express 
several transcription factors that are essential in granting early functional features 
(IL-4 production) and initiating cellular differentiation. Specifically, these immature 
CD4+ CD44Low NK1.1- iNKT cells begin exhibiting functional capabilities that are 
defined by the ability to produce Th2 cytokines upon stimulation 90. Both PLZF 
(BTB-ZF family transcription factor) and Gata-3 have been shown to contribute to 
this early functional attribute as shown in gene-targeted deficient mice 114,115. In 
addition to containing low numbers of iNKT cells, iNKT cells from PLZF-/- mice 
display a CD4+ CD44Low NK1.1- phenotype and produce low levels of IL-4 upon 
activation 115. Likewise, a deficiency in Gata-3 also results in a defect in both IL-4 
and IL-13 production by iNKT cells 114. Furthermore, Gata-3-/- mice also have a 
severe reduction in peripheral iNKT cells. But unlike PLZF-/- iNKT cells, Gata-3-/- 
iNKT cells display a mature NK1.1+ phenotype 114. It is uncertain if PLZF directly 
regulates Gata-3 as Gata-3 expression was not analyzed in PLZF-/- iNKT cells. 
Nevertheless, it is clear both are crucial for the early developmental events in iNKT 
cell biology. 
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The last stage of differentiation, which includes the up-regulation of NK1.1 and the 
ability to express IFN-γ, is dependent on T-bet expression 59. Specifically, T-bet 
expression by iNKT cells regulates various molecules including NK1.1, CXCR3, and 
CD122 expression. These cell surface molecules are crucial for various iNKT cell 
developmental events including thymic retention (CXCR3) and responsiveness to 
IL-15 (CD122). Moreover, T-bet also regulates various functional proteins including 
IFN-γ, granzyme B and perforin 59,116. As expected, T-bet-/- mice severely lack 
thymic and peripheral iNKT cells particularly the NK1.1+ iNKT cell population 116. 
Regarding cytokine production, T-bet-/- iNKT cells have a deficiency in IFN-γ 
production but still retain the capacity to produce IL-4 upon stimulation 59,116. Thus, 
T-bet is crucial in the transition from CD44High NK1.1- cells to CD44High NK1.1+ cells. 
In addition, it also endows mature iNKT cells with the ability to respond to IL-15 and 
the capability to produce IFN-γ. Although it is clear that T-bet is important for iNKT 
maturation, how T-bet is regulated in developing iNKT cells in vivo is not known. 
Together, these studies suggest that a complex network of transcription factors 
cooperate with each other to generate and maintain this unique functional T cell 
population. 
 
1.4.3 The role of IL-15 in iNKT cell biology. 
Like other IL-15-dependent lymphocytes, iNKT cells are severely reduced in mice 
deficient in IL-15 or any of its receptors 5,13,21,63. Specifically, IL-15-/- mice lack 
normal numbers of thymic and peripheral iNKT cells 13,34. In these mice, all 
differentiation stages are present; however, CD44High NK1.1+ cells are preferentially 
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lost. This is likely due to an increased sensitivity to IL-15 as CD44High NK1.1+ cells 
have higher expression of CD122 compared to the immature populations 34,116. In 
addition to its role in development, IL-15 is also important for iNKT cell homeostasis. 
Adoptive transfer experiments revealed iNKT cells do not undergo homeostatic 
proliferation or survive in IL-15-deficient mice 34,111. So similar to NK cells, IL-15 
appears to be required late during iNKT cell development and homeostasis 
particularly, as a survival and expansion factor.  
 
As mentioned in the prior sections, trans-presentation is the major mechanism for 
IL-15 delivery but the cell-type(s) trans-presenting IL-15 to iNKT cells has not been 
described. Prior studies using various IL-15Rα BM chimeras revealed IL-15Rα 
expression by either hematopoietic or non-hematopoietic cells partially recovers 
peripheral NK1.1+ T cell numbers 29. Unfortunately, this study did not specifically 
investigate effects on iNKT cells as CD1d-tetramers were not used and not all iNKT 
cells express NK1.1.  Moreover, neither the thymus nor the functions of iNKT cells 
were examined. As such, these results may have described the requirements for IL-
15Rα by conventional T cells expressing NK1.1 and may not be reflective of true 
iNKT cells. More recently, NF-κB activation was shown to control IL-15Rα 
expression by iNKT cells and presumed to enhance IL-15 signaling 117. Taken 
together, the phenotype of IL-15Rα-/- mice and the role of NF-κB in IL-15Rα 
expression makes it plausible that iNKT cells may respond to IL-15 through the IL-
15Rαβγ heterotrimeric complex and/or IL-15 trans-presentation. Nevertheless, the 
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requirement of IL-15Rα expression by iNKT cells and the cells they interact with is 
still unclear. 
 
So while IL-15 is clearly critical for the overall numbers of iNKT cells in the thymus 
and periphery, the source of IL-15 has not been identified. iNKT cells, like NK cells, 
interact with DCs, a known source of IL-15. Additionally, mice with genetic defects 
in the NF-κB family member, RelB, lack thymic DCs, medullary thymic epithelial 
cells and have a severe deficiency in iNKT cells 118-120. In RelB-/- mice, IL-15 mRNA 
levels are decreased in the thymic stroma suggesting non-hematopoietic cells may 
provide a source of IL-15 but this has not been analyzed 119. In the periphery, 
hepatic stellate cells (non-hematopoietic origin) provide a source of IL-15 and have 
been shown to maintain hepatic iNKT cells 121. Whether hematopoietic cells are a 
source of IL-15 in the liver is unclear; however, the liver microenvironment contains 
macrophages and DCs which are known IL-15-producing cells 122. So unlike the 
other IL-15-dependent populations far less is known about the role of IL-15 trans-
presentation during iNKT cell development and homeostasis. Lastly, whether IL-15 
contributes to other aspects of iNKT cell biology, such as functional maturation or 
activation of iNKT cells, has not been investigated.   
 
1.5 Statement of Objective. 
1.5.1 Known’s and unknowns of IL-15 in NK and iNKT cell biology. 
Both IL-15-/- and IL-15Rα-/- mice have a deficiency in NK and iNKT cells, which 
highlights the importance of both IL-15 and IL-15Rα in the development and 
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homeostasis of NK and iNKT cells 13,21. Intriguingly, both NK and iNKT cell 
development includes differentiation through multiple intermediate stages, tissue-
specificity and subsets with differing functional attributes.  After development is 
complete, homeostatic mechanisms are present that contribute to maintaining 
normal numbers of NK and iNKT cells in the periphery. Additional studies have also 
revealed IL-15 involvement in the activation of NK and iNKT cells 73,74. Thus, proper 
development and maintenance of NK and iNKT cells is a requisite for the protection 
from invading pathogens.  
Collectively, the past studies suggest the pleiotropic cytokine, IL-15, is a key 
regulator in NK and iNKT cell ontogeny. Yet, these past studies never addressed 
how IL-15 can control and discriminate between each event (differentiation, 
proliferation, survival and activation). Additionally, the cell-types trans-presenting IL-
15 to NK and iNKT cells during these events is currently unclear. These issues are 
further compounded by the fact that the periphery is seeded with a heterogeneous 
population of immature and mature NK and iNKT cells, and these populations 
reside together in multiple tissue sites 37,89. The finding that trans-presentation is a 
major mechanism of IL-15 delivery has generated great interest in identifying the 
“trans-presenting” cell type(s) and may provide clues behind the regulation of IL-15. 
Although progress has been made, the specific identity of these cells has remained 
elusive. Equally unclear is the expression of IL-15Rα on IL-15-responding cell-types 
as both cells have been shown to express IL-15Rα. Nevertheless, the finding that 
the expression of IL-15Rα by multiple IL-15-dependent cells is not required for their 
generation or maintenance supports the mechanism of IL-15 trans-presentation as 
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the major source of action 28-31. Thus, identifying the cell-type trans-presenting IL-15 
is essential in understanding NK and iNKT cell biology.  
 
1.5.2 Dissertation Objective and Hypothesis.  
The overall objective of this investigation was to determine the cellular function 
of IL-15 and the potential mediators of IL-15 trans-presentation that control the 
immunological niche of NK and iNKT cells in vivo. To execute this objective, I 
utilized bone marrow chimeras and transgenic mice (FIGURE 6) to dissect what 
cell-type trans-presents IL-15 to drive the differentiation, functional maturation, 
proliferation, survival and homeostasis of NK and iNKT cells. The central 
hypothesis of this dissertation is that IL-15 trans-presentation by distinctive IL-
15Rα-expressing cell-types drives critical immunological events in NK and iNKT cell 
ontogeny. My specific aims were to: AIM I: define the IL-15Rα+ cell-types driving 
the differentiation; proliferation; functional maturation and homeostasis of NK cells 
via IL-15 trans-presentation in the various NK cell tissue microenvironments. 
Specifically, in Ia) I analyzed the recovery of the various stages of NK cell 
development when IL-15Rα expression is restricted to hematopoietic and non-
hematopoietic cells; Ib) analyzed the role of IL-15Rα expression by NK cells in Ly49 
expression by generating mixed BM chimeras; and Ic) assessed the role of DC-
mediated IL-15 trans-presentation in NK cell development and homeostasis. In AIM 
II: define the IL-15Rα+ cell-types driving the differentiation; proliferation;  
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FIGURE 6. IL-15Rα Mouse Models. 
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FIGURE 6. IL-15Rα Mouse Models. 
The models used to investigate the cell-type(s) trans-presenting IL-15 to NK and 
iNKT cells. A) IL-15Rα BM chimeras were utilized to restrict IL-15Rα expression to 
either the hematopoietic or non-hematopoietic compartment. B) A mouse model that 
restricts IL-15Rα expression solely to CD11cHigh cells (both described in Chapter 5).  
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survival; functional maturation and homeostasis of iNKT cells via IL-15 trans-
presentation in the various iNKT cell tissue microenvironments. Specifically, in IIa) I 
analyzed the role of hematopoietic and non-hematopoietic cells in generating iNKT 
cells in the various tissue sites via IL-15 trans-presentation; and in IIb) assessed the 
role of DC-mediated IL-15 trans-presentation in iNKT cell development and 
homeostasis. Previous data that support my hypothesis revealed that IL-15 trans-
presentation by both hematopoietic and non-hematopoietic cells contribute to the 
generation of NK and iNKT cells in a tissue-specific fashion 29. The general 
rationale for my research was to identify the specific cell-types mediating the in vivo 
function of IL-15 and the parameters controlling the specific events in each niche in 
order to manage pathological and therapeutic conditions.  
 
I tested this hypothesis and accomplished the proposed objective by addressing the 
following two specific aims:  
 
Specific Aim 1 (Described in Chapter 2): I determined the cell-types driving the 
differentiation, proliferation, functional maturation and homeostasis of NK cells via 
IL-15 trans-presentation in the various NK cell tissue microenvironments. 
Specifically, I revealed DCs promote the development and homeostasis of NK cells 
via IL-15 trans-presentation by using a model wherein CD11c+ DCs are the sole 
cell-type trans-presenting IL-15 35. By using this model, I provided evidence that 
DCs contribute to the development and homeostatic maintenance of NK cells via IL-
15 trans-presentation. In addition, I have identified specific stages of NK cell 
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development in which IL-15 trans-presentation functions under steady-state 
conditions and identified what cellular compartment is trans-presenting IL-15 during 
these stages.  Lastly, I revealed IL-15Rα expression by NK cells is unnecessary for 
Ly49 expression. Overall, an additional role for NK-DC interactions has been 
identified whereby DCs support the developmental and homeostatic niche of NK 
cells in a tissue- and stage-specific manner. 
 
Specific Aim 2 (Described in Chapter 3): I identified the cell-types driving the 
differentiation, proliferation, functional maturation and homeostasis of iNKT cells via 
IL-15 trans-presentation in the various iNKT cell tissue microenvironments. In 
particular, I revealed the IL-15-driven events in iNKT cell development are mediated 
by distinct cell types via IL-15 trans-presentation, depending on the tissue 
microenvironment. In the thymus, radiation-resistant thymic stromal cells provided 
IL-15 for iNKT cell survival. Whereas in the periphery; both radiation-sensitive and -
resistant cells provided IL-15 for survival, proliferation and maturation.  DCs, a 
radio-sensitive cell, were also shown to be critical for the homeostasis of peripheral 
iNKT cells. Furthermore, IL-15 signaling was shown to impact the functional 
maturation and activation of hepatic iNKT cells. Overall, I have defined the tissue-
specific roles of IL-15 in iNKT cell biology and have identified the specific cells 
regulating the development, homeostasis, and activation of iNKT cells via IL-15 
trans-presentation. 
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CHAPTER 2 
 
The Role of IL-15 Trans-Presentation During the Development and 
Homeostasis of Natural Killer Cells. 
 
2.1 Introduction 
NK cells are an intricate part of the innate immune system providing a first line of 
defense against pathogens and transformed cells. What's more, NK cells can act as 
trigger to initiate or even boost the adaptive immune response. These features have 
been exploited in the clinical setting; yet, utilizing their full potential has been a 
perplexing challenge. To overcome this hurdle the scientific community must 
understand the biology of NK cells including the regulation of their development, 
maintenance and effector function.  
 
Given that the generation, maintenance and effector function of NK cells are 
dependent on IL-15 it is important to understand the basic biology between NK cells 
and IL-15. Since IL-15 can be delivered via trans-presentation it is essential to 
identify the source of IL-15 in individual microenvironments harboring NK cells. 
Identification of these tissue-specific IL-15Rα+ cells will provide a wealth of 
knowledge regarding how the development and maintenance of NK cells are 
regulated by IL-15.  
 
 43 
Currently, the source of IL-15 during NK cell development and homeostasis is 
unclear. Thus, I have investigated the cell-types driving the differentiation, 
proliferation, functional maturation and homeostasis of NK cells via IL-15 trans-
presentation in the various NK cell tissue microenvironments. 
 
2.2 Results 
“ 2.2.1 IL-15Rα expression by hematopoietic cells is essential for NK cell 
development. 
In prior BM chimera studies 29,67, the stages of NK cell development being 
recovered were not determined. Therefore, we generated various IL-15Rα 
BM chimeras to define the roles of IL-15 trans-presentation by hematopoietic 
and non-hematopoietic cells during NK cell development. Since NK cells 
develop in the BM and are abundant in the liver and spleen, these tissues 
were examine to assess NK cell recovery between the different groups 
(FIGURE 7). Similar to previous reports, the numbers of NK1.1+ CD3- cells in 
the BM were restored to 75% of control levels in chimeras expressing IL-
15Rα exclusively by hematopoietic cells (B6 BM  RKO host) (FIGURE 8). 
In the liver and spleen, NK cell generation was recovered to 32% and 50% of 
control levels, respectively revealing the hematopoietic cells as the dominant 
cell-type involved in the generation of NK cells (FIGURE 8). In comparison, 
expression of IL-15Rα by non-hematopoietic cells (RKO BM  B6 host) also  
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FIGURE 7. Requirement of IL-15Rα by hematopoietic and non-
hematopoietic cells in the generation of NK cells. 
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FIGURE 7. Requirement of IL-15Rα by hematopoietic and non-hematopoietic 
cells in the generation of NK cells. NK1.1+ CD3- cells recovered in the BM, liver 
and spleen of the various IL-15Rα bone marrow chimeras. Data are representative 
of three independent experiments, n = 8 mice per group. 
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FIGURE 8. The total number of NK cells recovered in BM chimeras. 
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FIGURE 8. The total number of NK cells recovered in BM chimeras. Absolute 
numbers of NK cells (NK1.1+ CD3- cells) in the respective tissues of the various IL-
15Rα bone marrow chimeras. IL-15Rα-/- BM into IL-15Rα-/- host (black bar), WT 
BM into IL-15Rα-/- host ( dark gray bar), IL-15Rα-/- BM into WT host (white bar), 
and WT BM into WT host (light gray bar). The absolute numbers were average of 3 
independent experiments, n= 8 mice per group. Error bars represent S.E., * p ≤ 
0.05.  
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generated NK cells albeit less significant than the hematopoietic 
compartment (FIGURE 8).  
 
Because NK cell development involves the transition through multiple stages 
to become a mature NK cell 47,48, the next step was to identify the stages of 
development regulated by each cellular compartment. This was 
accomplished by quantifying the following transitional subsets using 
differential expression of various cell surface markers. The phenotype of 
each stage were defined by the following cellular phenotype: NK precursors - 
CD122+ NK1.1– DX5– CD3–; immature - CD122+ NK1.1+ DX5– CD3–; early 
mature [M1] - CD122+ NK1.1+ DX5+ CD11bLow CD3–; and late mature [M2] - 
CD122+ NK1.1+ DX5+ CD11bHigh CD3– NK cells (FIGURE 9). When IL-15Rα 
expression was restricted to hematopoietic cells (WT BM  IL-15Rα–/– 
chimeras), the development of NK cells at all stages was completely 
recovered in the BM as compared with WT BM  WT chimeras (FIGURE 
10). In the liver and spleen, IL-15Rα+ hematopoietic cells significantly 
enhanced immature and M1 NK cells, but restoration of the M2 population 
was incomplete (FIGURE 10). When IL-15 trans-presentation is mediated by 
the non-hematopoietic compartment (RKO BM  WT host) the immature NK 
cells could be substantially recovered in the BM, but the M1 and M2 NK cells 
were only minimally affected, whereas the non-hematopoietic cells had little 
role in the liver and spleen (FIGURE 10). Taken together, this shows that  
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FIGURE 9. NK cell development in BM Chimeras. 
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FIGURE 9. NK cell development in BM Chimeras. Representative flow 
cytometry data from the BM of the stages of NK cell development. NK 
precursors are characterized as CD122+ NK1.1- cells; Immature are CD122+ 
NK1.1+ DX5-; Early mature (M1) display CD122+ NK1.1+ DX5+ CD11bLow 
phenotype; and Late mature (M2) are a CD122+NK1.1+DX5+CD11bHigh 
population. 
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FIGURE 10. Recovered developmental stages and tissue distribution of 
NK cells in IL-15Rα BM chimeras.  
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FIGURE 10. Recovered developmental stages and tissue distribution of 
NK cells in IL-15Rα BM chimeras. Lymphocytes were isolated from the 
indicated tissues of IL-15Rα-/- BM chimeras 8-12 weeks after irradiation and 
BM reconstitution.  Numbers of NK cells at the various developmental stages 
in the respective tissues of IL-15Rα-/- BM chimeras is shown and 
distinguished by various cell surface markers (average of 3 independent 
experiments, n= 8 mice per group) Error bars represent S.E., * p ≤ 0.05.
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hematopoietic cells are the dominate cell-type to trans-present IL-15 during 
NK cell development and they are crucial for the late stage of maturation 
especially in the BM, whereas the non-hematopoietic compartment appears 
to assist in the early stages of NK cell development and has no effect on late 
maturation.  
 
To exclude the possibility that donor-derived BM non-hematopoietic cells 
were contributing to the effects we observed, the same scheme of generating 
BM chimeras was also performed using sorted lineage- CD45+ cKit+ Sca-1+ 
stem cells. Likewise, this group of chimeras also demonstrated the 
importance of IL-15Rα expression by hematopoietic cells in driving NK cell 
development (data not shown). Overall, the data demonstrates hematopoietic 
cells are the predominant cell-type to drive the differentiation of immature 
cells into mature NK cells via IL-15 trans-presentation. Additionally, these 
observations suggest IL-15Rα+ non-hematopoietic cells together with IL-
15Rα+ hematopoietic cells are critical in the early events of NK cell 
differentiation; however, the former has a minimal role in late development. 
2.2.2 Exclusive expression of IL-15Rα to CD11c+ DCs partially restores NK 
cell numbers in BM and periphery.  
Since IL-15Rα+ hematopoietic cells emerge essential for NK cell 
development, we asked if DCs were the main cell-type trans-presenting IL-15 
to NK cells. To determine how the effect of IL-15Rα restricted to CD11c+ 
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cells compares to the effect of IL-15Rα expression by hematopoietic cells, 
recovery of the NK cells was examined in CD11c/IL-15Rα Tg (Tg) mice bred 
on the IL-15Rα–/– background 35. This transgenic mouse restricts the 
expression of IL-15Rα to CD11cHigh cells (FIGURE 6), thus can be utilized as 
a model where only DC can trans-present IL-15. As stated above, NK cells 
are present in the BM, liver and spleen, so each of these tissues were 
analyzed in the Tg mice and compared with IL-15Rα–/– and WT (C57BL/6) 
mice for total NK1.1+ CD3– cells. In each of these tissues, the frequency and 
total numbers of NK cells were significantly increased in the Tg mice 
compared with total numbers of NK cells in the IL-15Rα–/– mice, with the 
recovery being most dramatic in the BM (FIGURE 11). These data reveal 
reconstitution of IL-15Rα solely to the DC compartment contributes to the 
generation of total NK cell (NK1.1+ CD3–) numbers.  
2.2.3 IL-15 trans-presentation by DCs drives specific stages of NK cell 
development. 
The next step was to identify the stages of NK cell development regulated by 
DCs. In all tissues examined, the complete absence of IL-15Rα resulted in a 
dramatic decrease in the number of both of the mature (M1 and M2) NK cell 
subsets, a moderate decrease in immature NK cells but no deficiencies in NK 
precursors (FIGURE 12). Within the BM, IL-15 trans-presentation by DCs 
was very efficient in restoring the immature population and partially restored 
the early (M1) and late (M2) stages of NK cell development when compared  
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FIGURE 11. IL-15Rα+ DCs influence in the generation of NK cells. 
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FIGURE 11. IL-15Rα+ DCs influence in the generation of NK cells. A, 
NK1.1+ CD3- cells recovered in the BM, liver and spleen of IL-15Rα-/- (left 
column), CD11c/IL-15Rα Tg (middle column) and B6 (right column) mice 
were analyzed by flow cytometry. Data is representative of three independent 
experiments. B, Absolute numbers of NK cells (NK1.1+ CD3- cells) in the 
respective tissues of IL-15Rα-/- (black bar), CD11c/IL-15Rα Tg (gray bar) and 
B6 (white bar) mice were calculated (average of 3 independent experiments, 
n= 7 mice per group).  Error bars represent S.E., * p ≤ 0.05.  Numbers above 
bars represent percent of Wt levels. Copyright 2009. The American 
Association of Immunologist, Inc.
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FIGURE 12. Recovered developmental stages and tissue distribution of 
NK cells by DC-mediated IL-15 trans-presentation.  
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FIGURE 12. Recovered developmental stages and tissue distribution of 
NK cells by DC-mediated IL-15 trans-presentation.  A-C, Stages of NK 
cell development were identified by flow cytometric analysis of BM, spleen, 
and liver isolated from each group of mice (IL-15Rα-/-, CD11c/IL-15Rα Tg, 
and Wt mice). Representative flow cytometry data from the BM is shown in 
panel A. B, absolute numbers of NK cells at the various developmental 
stages in the respective tissues (average of 3 independent experiments, n= 7 
mice per group, Error bars represent S.E., * p ≤ 0.05.) in the indicated 
groups.  C, NK cell subsets distinguished by their cell surface expression of 
CD27 and CD11b in the BM (top row) and spleen (bottom row) from each 
group of mice.  Flow cytometric plots are representative of three independent 
experiments (n=7 for each group of mice). Copyright 2009. The American 
Association of Immunologist, Inc.
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with the IL-15Rα–/– mice (FIGURE 12b). Nevertheless, this level of recovery 
in the BM is not equivalent to what was observed in WT BM  IL-15Rα–/– 
chimeras and indicates that other non-CD11c– hematopoietic cells are 
essential in the transition into the M2 stage of development (FIGURE 12b). In 
the spleen, IL-15Rα+ DCs recovered immature NK cells and significantly 
enhanced both M1 and M2 populations (FIGURE 12b). Similar to the BM and 
spleen, the presence of IL-15Rα+ cells in the liver also enhanced the 
development of immature and mature NK cells but was most effective in 
recovering the M1 stage compared with WT mice (FIGURE 12b). These 
effects were not observed so much in the spleen and liver of IL-15Rα–/– BM 
 WT chimeras, suggesting that CD11c+ cells are the dominant 
hematopoietic cells trans-presenting IL-15 to NK cell in the periphery 
(FIGURE 12b)  
Stages of mouse NK cell development and maturation have also been 
distinguished by the decreased expression of CD27 and the increased 
expression of CD11b with the earliest stage being the CD27+CD11bLow, 
which gives rise to a CD27+CD11b+ population and eventually a terminally 
differentiated CD27LowCD11b+ subset 51. Therefore, we assessed the 
recovery of these three stages in the CD11c/IL-15Rα Tg mice. In our analysis 
of CD27 and CD11b populations in the BM, similar proportions of 
CD27+/CD11bLow and the CD27+/CD11b+ cells were observed in the 
CD11c/IL-15Rα Tg and WT mice, whereas the majority of the NK cells in IL-
 60 
15Rα–/– mice displays a CD27+CD11bLow phenotype (FIGURE 12c). 
Conversely, whereas all three populations were prevalent in the spleen of WT 
mice, the CD27Low/CD11b+ phenotype was deficient in the CD11c/IL-15Rα 
Tg mice (FIGURE 12c). This analysis suggests that IL-15 trans-presentation 
by DC is insufficient for maturation of CD27Low/CD11b+ NK cells, which 
preferentially reside outside the BM.  
 
2.2.4 IL-15Rα+ DC promotes the up-regulation of Ly49 receptors in 
developing NK cells. 
Our findings so far demonstrate IL-15 trans-presentation by CD11c+ DC 
subsets primarily act at the immature stage of NK cell development. During 
this stage, expression of activating and inhibitory receptors (CD94/NKG2 and 
Ly49), which are important for NK cell licensing, are induced 44,45. Although 
there is evidence that both IL-15 and IL-15Rα participate in the acquisition of 
Ly49 receptors 31, the cell type providing IL-15 for the transition to a Ly49+ 
population is unclear. Thus, the cell surface expression of various activating 
and inhibitory receptors by splenic NK cells was analyzed in IL-15Rα–/–, 
CD11c/IL-15Rα Tg, and WT mice. NK cells from CD11c/IL-15Rα Tg and WT 
mice, but not IL-15Rα–/– mice, expressed normal levels of the activating 
receptor Ly49H, as well as the inhibitory receptors Ly49G2 and Ly49 I 
(FIGURE 13a and b). Conversely, expression of CD94, NKG2 A/C/E, 2B4, 
and NKG2D was similar in the three groups of mice indicating that their  
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FIGURE 13. DCs drive Ly49 expression of immature NK cells. 
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FIGURE 13. DCs drive Ly49 expression of immature NK cells. A and B, 
Expression of Ly49 activating and inhibitory receptors on splenic NK cells as 
detected by flow cytometry in WT (top row), CD11c/IL-15Rα Tg (middle row) 
and IL-15Rα-/- (bottom row) mice. A, histograms showing representative data 
from two independent experiments. B, graph depicts the average percent of 
the population that is positive for the indicated Ly49 molecule (n=4 per 
group). Error bar represent S.E., * p ≤ 0.05.). C, in vitro acquisition of the 
Ly49 repertoire by BMDC.  Ly49- NK cells were sorted from spleens of WT 
mice and cocultured with DCs generated from BM of either IL-15Rα-/- (left 
plot) or WT (right plot) mice with GM-CSF. Plots show expression of Ly49 on 
NK1.1+ CD3- cells at the end of coculturing.  Data are representative of two 
independent experiments. D, cell surface expression of Ly49 activating and 
inhibitory receptors by NK cells derived from Wt (top row) and IL-15Rα-/- 
(bottom row) BM donor cells. BM cells from Wt (CD45.1+/CD45.2+) and IL-
15Rα-/- (CD45.2+) were injected in equal proportions into irradiated CD45.1+ 
Wt hosts.  After reconstitution of hematopoietic cells (~8-10 weeks later), the 
respective donor-derived NK1.1+ CD3- cells in the spleen were identified 
based on CD45 isoform expression. Plots are representative of three 
experiments (n=5 mice/group). Copyright 2009. The American 
Association of Immunologist, Inc.
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acquirement is independent of IL-15 (data not shown). This data suggest that 
IL-15 trans-presentation by CD11c+ DCs up-regulates the expression of the 
Ly49 repertoire on NK cells in vivo.  
To directly demonstrate that DCs drive the differentiation of Ly49– NK cells 
into Ly49+ NK cells, we determined whether IL-15 trans-presentation by 
purified DCs could drive this differentiation process in vitro. Therefore, Ly49– 
NK cells were isolated from WT splenocytes by flow cytometric sorting and 
then cocultured with BM-derived DCs from either IL-15Rα–/– or WT mice. 
After a 5-day incubation period, NK cells cocultured in the presence of IL-
15Rα+ WT DCs expressed the various Ly49 markers whereas NK cells 
cultured with IL-15Rα–/– DCs did not (FIGURE 13c), supporting our in vivo 
findings that DC-mediated IL-15 trans-presentation drives a specific 
differentiation event during NK cell development.  
To exclude the possibility that IL-15Rα expression by NK cells is required for 
Ly49 expression as suggested by previous studies 67, mixed BM chimeras 
were generated by injecting equal amounts of IL-15Rα–/– BM 
(CD45.1+/CD45.2+) and WT BM (CD45.2+) into lethally irradiated congenic 
WT mice (CD45.1+). After reconstitution of the hematopoietic compartment, 
the various Ly49 receptors (I, H, G2, and A/D) were expressed at similar 
levels by NK cells derived from either IL-15Rα–/– and WT cells coexisting in 
the same mice (FIGURE 13d). This finding demonstrates that IL-15Rα 
expression by NK cells is not necessary for Ly49 up-regulation. Altogether, 
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these findings reveal IL-15 trans-presentation is critical in the acquisition of 
the activating and inhibitory Ly49 receptors, and DCs are capable of driving 
this specific differentiation event required for functional maturation.  
2.2.5 Proliferation of NK cells is restored by DC-mediated IL-15 trans-
presentation. 
During NK cell development, expansion of successfully differentiated NK 
cells is an important component of NK cell development. Since IL-15 is 
known to induce proliferation 68,71, we determined whether IL-15Rα+ DCs 
affects cell expansion occurring during NK cell development. To examine this 
role, the amount of BrdU incorporation in the immature (NK1.1+ DX5– CD3–) 
and mature (NK1.1+ DX5+ CD3–) NK cells was compared among the three 
groups of mice. In the BM, BrdU incorporation by NK cells in IL-15Rα-/- was 
dramatically low in both immature and mature populations in comparison to 
WT mice (FIGURE 14a and b). In Tg mice, IL-15Rα+ DCs enhanced the 
incorporation of BrdU by both immature and mature NK cells found in the BM 
(FIGURE 14a and b). In contrast, the absence of IL-15Rα or the presence of 
IL-15Rα+ DCs had no affect on peripheral NK cell proliferation (FIGURE 14a 
and b). Collectively, the above data show the expansion of mature NK cells 
occurring in the BM is dependent on IL-15 trans-presentation and partially 
driven by CD11c+ DCs.  
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FIGURE 14. DCs assist in the expansion of NK cells in the BM. 
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FIGURE 14. DCs assist in the expansion of NK cells in the BM. A, 
Representative histograms showing the in vivo BrdU incorporation (3 weeks 
of BrdU [0.8mg/ml] in drinking water) as detected by flow cytometry in (A) 
immature (NK1.1+ DX5- CD3-) and mature NK cells (NK1.1+ DX5+ CD3-) 
found in the BM (top row), spleen (middle row), and liver (bottom row) in the 
three groups of mice. B, Graph depicts the average BrdU incorporation in 
immature and mature NK cells from the individual groups in two independent 
experiments (n=4 mice/group). Copyright 2009. The American 
Association of Immunologist, Inc.
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2.2.6 Survival of mature NK cells is mediated by DCs trans-presenting IL-15. 
After development is complete, maintenance of mature NK cells is 
predominately mediated by survival of NK cells, rather than by homeostatic 
proliferation, and is highly dependent on IL-15 trans-presentation 32,68,71,111. 
Lymphopenia-induced proliferation of NK cells also uses IL-15 trans-
presentation and has recently been shown to be mediated by DCs 123. 
Whether DCs also maintain the survival of mature NK cells via IL-15 trans-
presentation under steady-state conditions has not been demonstrated. To 
examine the role of IL-15 trans-presentation by DCs in NK cell homeostasis, 
splenic NK cells from WT mice (CD45.1+) were labeled with CFSE and 
transferred into IL-15Rα–/–, CD11c/IL-15Rα Tg, and WT mice (all CD45.2+). 
After 3 wk, the BM, liver, and spleen were extracted and analyzed for the 
presence of donor NK cells (FIGURE 15a). In all tissues examined, the 
number of donor NK cells was severely decreased (between 0.5 and 3% of 
WT levels) in IL-15Rα–/– hosts compared with that found in WT mice 
highlighting the crucial role of IL-15Rα in NK cell survival (FIGURE 15a). In 
CD11c/IL-15Rα Tg mice, the number of donor NK cells was recovered to 46 
and 48% of WT levels in the liver and spleen, respectively. Examination of 
cell division via CFSE dilution indicated homeostatic proliferation did not 
occur during this time (FIGURE 15b), as reported previously 32,70. Since 
recovery of donor NK cells was not as prevalent in the BM of CD11c/IL-15Rα 
Tg mice, it suggests that either mature NK cells do not migrate to the BM as 
efficiently as to the spleen or liver or that either CD11c+ cells in the BM do not  
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FIGURE 15. DCs support the maintenance of peripheral NK cells. 
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FIGURE 15. DCs support the maintenance of peripheral NK cells. A, 
Graph shows the average numbers of donor NK cells (gated on CD45.1+ 
NK1.1+ DX5+ CD11b+ CD3- cells) recovered in the BM, spleen, and liver three 
weeks after the adoptive transfer into congenic CD45.2+ IL-15Rα-/- (black 
bar), CD11c/IL-15Rα Tg (gray bar) and WT (white bar) mice. Error bars 
represent S.E. and the numbers above bars represent percent of Wt levels, * 
p≤ 0.05. B, Dilution of CFSE by donor cells found in the spleen of the three 
hosts. Plots are representative of two individual experiments (n=4 for each 
group). Copyright 2009. The American Association of Immunologist, Inc.
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provide survival signals to mature NK cells. Altogether, the data demonstrate 
that DCs indeed participate in mediating survival of mature NK cells by trans-
presenting IL-15.  
 
2.2.7 NK cells developing in CD11c/IL-15Rα Tg mice are functional and do 
not show signs of aberrant activation. 
The highlight of NK cell development is the generation of NK cells that can 
mount an early immune response regulated by cytokine activation or down-
regulation of self MHC class Ia 38. NK cells recovered by IL-15Rα+ DCs 
display a phenotype that is associated with functional maturation 47. Since 
recent reports 73,74 demonstrate that DCs can activate NK cells via IL-15 
trans-presentation, it is possible that Tg expression of IL-15Rα to DCs could 
lead to aberrant NK cell activation. To examine the activation and functional 
status, NK cells were sorted from CD11c/IL-15Rα Tg and WT mice and 
stimulated with plate-bound NK1.1 Ab or media alone 44. After a 5-h 
incubation period, the production of IFN-γ and cytolytic potential as 
determined by CD107α cell surface mobilization was analyzed. Similar to WT 
NK cells, NK cells from the CD11c/IL-15Rα Tg mice produced IFN-γ and 
expressed CD107α only in response to NK1.1 stimulation (FIGURE 16a). In 
addition, the expression level of the activation-enhanced cell surface marker, 
CD69, by unmanipulated NK cells from the CD11c/IL-15Rα Tg mice was 
similar to WT NK cells (FIGURE 16b). Taken together, our data suggest DC- 
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FIGURE 16. NK cells derived by DC-mediated IL-15 trans-presentation 
are functional but not activated under steady-state conditions. 
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FIGURE 16. NK cells derived by DC-mediated IL-15 trans-presentation 
are functional but not activated under steady-state conditions. A,  
Effector function of NK cells.  NK cells sorted from spleens of either WT or 
CD11c/IL-15Rα Tg mice were incubated for five hours in the absence (top 
row) or presence (bottom row) of plate-bound anti-NK1.1 antibody.  
Intracellular IFN-γ production and CD107 cell surface mobilization were 
measured via flow cytometry as indicators of effector function. Plot is 
representative of two independent experiments. B, Ex vivo comparison of the 
cell surface expression of the activation-induced marker, CD69, by splenic 
NK cells from Wt or CD11c/IL-15Rα Tg mice. Copyright 2009. The 
American Association of Immunologist, Inc.
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mediated IL-15 trans-presentation during steady-state conditions does not 
activate NK cells but rather generates functionally mature NK cells. 
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2.3 Discussion 
Interactions occurring between DC and NK cells have typically been 
described in the context of an immune response 124. For example, it has been 
reported that DC-mediated IL-15 trans-presentation activates NK cells both in 
vitro and in vivo 73,74. But whether DCs also participate in NK cell ontogeny by 
providing IL-15 has not been described. In this chapter, I provide evidence 
that DC indeed participate in NK cell development as well as in the 
homeostatic maintenance of NK cells via IL-15 trans-presentation. 
Furthermore, I identify specific stages of NK cell development where IL-15 
trans-presentation by CD11c+ and CD11c– hematopoietic cells preferentially 
occurs highlighting an important role for cell-specific IL-15 trans-presentation 
in NK cell functional maturation.  
BM stromal cells have long been regarded as the important cell-type 
controlling NK cell development 64-66. Therefore, it may be unexpected that 
DCs also mediate some of the functions previously attributed to BM stromal 
cells. Nonetheless, the previous studies examining BM stromal cells did not 
exclude the possibility that other cell types have overlapping functions. 
Confusion can also arise as a result of ambiguous and generic terminology 
used to define stromal cells. Although "stromal" is generally used to describe 
structural support cells, the more accepted definition regarding BM stromal 
cells refers to radiation resistant cells, which are believed to be non-
hematopoietic. In contrast, others have described BM stromal cells as 
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fibroblast-like cells that can be isolated from the BM but can reconstitute 
hematopoietic cells 125. More importantly, the conclusions made in this 
present study are based on the definition of BM stromal cells that was used 
in prior studies i.e., activity attributed to radiation-resistant cells in BM 
chimera models 64-66. Overall, the present study adds to these previous 
findings showing other cell types, which are CD11c+ can also provide IL-15 to 
NK cells during early events of development.  
I can only speculate as to why NK cells use IL-15 by both non-hematopoietic 
and hematopoietic cells. The BM is an abundant site for hematopoiesis. 
Since non-hematopoietic BM stromal cells are also involved in the 
development of other cell types such as B cells 126, it is possible that there is 
competition to receive resources from this cell type. Therefore, it would be 
advantageous for NK cells if they weren’t completely dependent on stromal 
cells for their IL-15. Second, IL-15 is up-regulated by TLR ligands 127, which 
are a component of the adaptive response to pathogens. Since DCs are very 
efficient in responding to TLR stimulation, DCs may have evolved as the 
predominant cell-type expressing IL-15. With time, the necessity for IL-15 to 
be stimulated by TLR was lost by DCs, leaving this cell type as a promoter of 
NK cell development.  
In this present study, I specifically demonstrate IL-15Rα+ DCs are efficient in 
driving the differentiation of immature and DX5+ NK cells (M1) and inducing 
acquisition of Ly49 expression while having a minor role in the transition of 
 76 
late stages of NK cell development (i.e., up-regulating CD11b and down 
regulating CD27). This role of DCs at specific stages of NK cell development 
suggests that distinct niches of NK cell development likely exist in the BM. 
Because conventional DCs are present in the BM at a low frequency and 
CD11c+ cells are a heterogeneous population containing CD11c+ 
plasmacytoid DCs and DC precursors 128,129, the precise phenotype of the 
cells mediating these activities is not clear. In our hands, detection of cell 
surface IL-15 and IL-15Rα by CD11c+ BM cells is found by putative DC 
precursors but not plasmacytoid DCs. Thus, a cell type contained within the 
putative DC precursor population may be a DC subset mediating IL-15 trans-
presentation. Despite the effectiveness of DCs in providing IL-15 during the 
early stages of NK cell development, trans-presentation of IL-15 by CD11c+ 
cells alone was insufficient in mediating all the IL-15 events attributed to IL-
15Rα+ hematopoietic cells, especially in the late stages of NK cell 
development. This finding highlights an unrecognized role for other CD11c– 
hematopoietic cells in NK cell development that may not have been 
previously identified; this may be because the late stages of NK cell 
development are not crucial for functional maturation but rather for mediating 
NK cell expansion. Identifying these other IL-15 trans-presenting 
hematopoietic cells involved in NK cell development may provide future 
insight on how best to improve NK cell expansion.  
In the peripheral tissues, the restricted expression of IL-15Rα to CD11c+ cells 
had less of an impact on recovery of normal NK cell numbers than in the BM. 
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Because the effects of limiting IL-15Rα expression to CD11c+ cells was 
similar to that when restricted to all hematopoietic cells, we speculate that 
conventional DCs are the predominate hematopoietic cells mediating IL-15 
trans-presentation outside of the BM. On the basis of my data, the function of 
IL-15 trans-presentation in these peripheral tissues is more geared toward 
the homeostatic maintenance of NK cells. With the presence of precursors 
and developmental intermediates located in the peripheral tissues, it is 
possible that NK cell developmental niches can occur outside of the BM, but 
whether some residual differentiation occurs in these sites is still uncertain.  
The functional attributes of NK cells are greatly dependent on acquiring 
various activating and inhibitory receptors 44. The expression of these 
receptors, specifically the various Ly49 receptors, has been shown to be 
dependent on NK cells expressing IL-15Rα 31. In contrast, analysis from our 
Tg mice and the BM chimera models demonstrate that Ly49 expression is 
independent of IL-15Rα expression by NK cells. Past research has 
suggested that the addition of only IL-15 to NKp cultures drove the 
differentiation of NK cells; however, this differentiated population was 
negative for the Ly49 repertoire 130. The up-regulation of the Ly49 repertoire 
appeared by NK cells only in the presence of stromal cells and IL-15 131,132. 
These observations suggested that a cell-cell interaction was needed to 
acquire the Ly49 receptors, and IL-15 alone was not enough. More recently, 
Huntington et al. 133 revealed that although IL-15 provides survival signals to 
NK cells, the up-regulation of killer Ig-related receptors by NK cells was 
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independent of such survival signals and dependent on IL-15 trans-
presentation. Thus, we add new insight into the acquisition of the Ly49 
repertoire by showing that DC-mediated IL-15 trans-presentation can drive 
this event previously shown to be mediated by BM stromal cells 131,132; it also 
provides further support for the notion that IL-15 is essential in up-regulating 
the Ly49 repertoire. More importantly, since acquiring the various Ly49 
inhibitory receptors is crucial in NK cell education, our findings demonstrate 
that IL-15 trans-presentation by DCs participates in a crucial first step for this 
event. In addition to the early requirement for Ly49 expression, DCs may 
directly mediate NK cell education as DCs express the various ligands that 
interact with NK cell receptors 20. Interestingly, since it has been reported that 
IL-15 up-regulates MHC class I Ag-processing machinery in human DCs 134, 
IL-15 may also regulate NK cell education by acting on the DCs to promote 
the expression of ligands for Ly49.  
After NK cell education, expansion of maturing NK cells is an important late 
event in the developmental process. In my findings using transfers of mature 
NK cells, NK cell proliferation was not observed, which is consistent with 
previous studies showing maintenance of mature NK cells is mediated by 
survival 32,70. However, since mature NK cells in the periphery were BrdU+, I 
reason that cell division occurred before exiting the BM. Since I observed that 
the numbers of late-stage mature NK cells and proliferation were deficient in 
the CD11c/IL-15Rα Tg mice, one could have suspected that licensing and/or 
functional maturation is incomplete. In addition, licensed NK cells are also 
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believed to possess enhanced proliferation potential over unlicensed NK cells 
44
. However, since I demonstrate that NK cells from CD11c/IL-15Rα Tg mice 
have normal Ly49 expression and functional attributes, I believe these NK 
cells are functionally mature but have not received an adequate expansion 
signal. Overall, the minor loss in proliferation appears to be independent of 
NK cell licensing and possibly dependent on other IL-15Rα+ cell-types. “” 135 
After the publication of my findings 135, Mortier et al 122 reported the phenotype 
observed in IL-15Rα flox mice interbred to CD11c-Cre Tg (deletion of IL-15Rα in 
DCs) or LysM-Cre Tg (deletion of IL-15Rα in macrophages) mice. In both models, 
peripheral NK cells were reduced in numbers but not affect was observed for BM 
NK cells. Specifically, a reduction in the total number of mature CD27- CD11b+ 
splenic NK cells was observed and attributed to a loss in CD27+ CD11b+ NK cell 
proliferation. Consequently, it was concluded that DCs (and macrophages) were 
crucial for the generation of mature peripheral NK cells. Similarly, my data revealed 
this mature CD27- CD11b+ NK population was also reduced in the periphery and 
BM but the models used in my study, had either DCs as the only cell-type 
expressing IL-15Rα or all hematopoietic cells expressing IL-15Rα 135. Thus, it is 
unlikely that only DCs and macrophages are required for this late stage of NK cell 
development as stated by Mortier and colleagues 122. Furthermore, the CD11c 
promoter has been shown to spill over into non-DCs including monocytes, 
macrophages, neutrophils, NK, B and T cells.  
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Regarding NK cell homeostasis, Mortier et al 122 revealed DCs and macrophages 
had no role in the homeostatic maintenance of NK cells; however, I revealed DCs 
play a significant role in the maintenance of peripheral NK cells. These different 
results could be due to the time points being assessed: Mortier et al 122 analyzed 
the recovery of NK cells at 4 hour, 2 and 7 days and I analyzed the recovery of NK 
cells 21 days post-transfer 135. It is plausible that donor NK cells transferred into 
CD11c-Cre/IL-15Rα floxed mice would decline in number if mice were analyzed 
after a longer time period. Overall, both reports reveal: i) DCs (or macrophages) are 
capable of trans-presenting IL-15 during NK cell development but are not the single 
cell-type crucial for the generation of mature NK cells; and ii) the development and 
homeostasis of NK cells is a complex and continuous event that is regulated by IL-
15 trans-presentation by cells of both hematopoietic and non-hematopoietic origin. 
In conclusion, I have identified the cell-types regulating the development and 
homeostasis of NK cells via IL-15 trans-presentation in the various tissue 
microenvironments occupied by NK cells.  
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CHAPTER 3 
 
The Role of IL-15 Trans-Presentation During the Development and 
Homeostasis of Invariant Natural Killer T Cells. 
 
3.1 Introduction 
The compelling features of iNKT cells, differential cytokine production and 
subsequent immune regulation, make these innate-like cells influential in various 
immunological responses. The involvement of iNKT cells in these responses can be 
advantageous or harmful to the host. The recent finding that various glycolipids can 
modify the cytokine production of iNKT cells enhances the potential of iNKT cells in 
the clinic. Nevertheless, a full comprehension of how the development and 
homeostasis of iNKT cells occur is lacking. 
  
Since iNKT cells are very similar to NK cells with regards to IL-15-dependency it is 
likely IL-15 regulates other iNKT developmental events like functional maturation. 
Furthermore, since tissue-specific iNKT cells exist with varying functional attributes 
it is vital to understand the cellular cues the microenvironment provides during the 
development and homeostasis of iNKT cells. Thus, identifying the source of IL-15 in 
each iNKT cell microenvironment will prove fundamental in understanding the true 
nature of IL-15 in iNKT cell biology. 
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Presently, the exact role of IL-15 during the development and homeostasis of iNKT 
cells is unclear as is the source of IL-15. Therefore, I have identified the cell-types 
driving the differentiation, proliferation, functional maturation and homeostasis of 
iNKT cells via IL-15 trans-presentation in the various iNKT cell tissue 
microenvironments. 
 
3.2 Results 
“ 3.2.1 Radiation-resistant cells are crucial in providing IL-15 during 
intrathymic iNKT cell development. 
Presently it is unclear which cells require IL-15Rα expression for iNKT cell 
development. Therefore, BM chimeras were generated to assess the role of 
IL-15 trans-presentation by hematopoietic or non-hematopoietic cells in 
restoring thymic and peripheral iNKT cells. Accordingly, iNKT cells were 
detected in the thymus, liver, and spleen in the 4 groups of BM chimera mice 
using CD1d-tetramers (FIGURE 17). IL-15Rα expression by non-
hematopoietic cells (IL-15Rα-/-BMWT host) recovered the frequency and 
total numbers of iNKT cells in the thymus similar to that found in WT 
chimeras (WT BMWT) (FIGURE 17b).  Conversely, the frequency and 
absolute numbers of thymic iNKT cells were still very much deficient when IL-
15Rα expression was expressed solely by hematopoietic cells (WT BMIL-
15Rα-/-) to a level that was similar to IL-15Rα-/- chimeras (IL-15Rα-/-BMIL-
15Rα-/-) (FIGURE 17b). Among peripheral iNKT cells in the liver, both IL-
15Rα+ hematopoietic or non-hematopoietic cells significantly increased the  
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FIGURE 17. Tissue-specific recovery of iNKT cells in IL-15Rα BM 
chimeras  
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FIGURE 17. Tissue-specific recovery of iNKT cells in IL-15Rα BM 
chimeras.  A-C, Tissue-resident iNKT cells or iNKT subsets were identified 
by flow cytometric analysis in the thymus, spleen, and liver of IL-15Rα-/- BM 
chimeras 8-10 weeks after irradiation and BM reconstitution by flow 
cytometric analysis. A. representative flow cytometric plots of CD1d-
tetramer+CD3+ cells from the indicated tissues. B, absolute numbers of CD1d 
tetramer+ cells in the respective tissues from the indicated groups  Error bars 
represent S.E.M. and the numbers above bars represent percent of WT 
levels * p ≤ 0.05. Data were average from 3 independent experiments, n= 9 
mice per group for the thymus; n=8 for the liver and spleen. Statistical 
significance was determined by unpaired Student t test. "This research was 
originally published in Blood Online. Eliseo F. Castillo, Luis F. Acero, 
Spencer W. Stonier, Dapeng Zhou, and Kimberly S. Schluns Thymic 
and peripheral microenvironments differentially mediate development 
and maturation of iNKT cells by IL-15 transpresentation Blood First 
Edition Paper, prepublished online June 25, 2010;DOI 10.1182/blood-
2010-03-277103.”
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levels of iNKT cells (~65% of control) compared to that in the complete 
absence of IL-15Rα (~19% of control) (p<0.05) (FIGURE 17b). In contrast to 
hepatic iNKT cells, splenic iNKT cells had minimal requirements for IL-15Rα 
as the number of iNKT cells in the complete absence of IL-15Rα was ~64% 
of control levels. While the numbers of splenic iNKT cells were increased by 
both IL-15Rα+ hematopoietic or non-hematopoietic cells, these differences 
were not significant.  Surprisingly, IL-15Rα+ hematopoietic cells increased 
the total number of NKT cells in the liver and spleen albeit the reduction of 
iNKT cell numbers in the thymus (FIGURE 17b).  In addition, even though 
normal numbers of iNKT cells were produced in the thymus by non-
hematopoietic cells, expression of IL-15Rα in the periphery by both 
hematopoietic and non-hematopoietic cells was required to maintain normal 
levels of iNKT cells (FIGURE 17b).  Regarding CD4+ and DN iNKT subsets, 
both subsets were equally dependent on IL-15Rα expression despite cell-
restricted expression (data not shown). Collectively, these findings suggest 
thymic iNKT cell development utilizes the non-hematopoietic cell 
compartment for IL-15 trans-presentation while peripheral iNKT cells receive 
IL-15 signals from both non-hematopoietic and hematopoietic cells.  
Remarkably, peripheral iNKT cell numbers can recover from a defect in 
thymic iNKT development indicating the importance of late developmental 
events occurring post-thymically. 
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3.2.2 DCs trans-present IL-15 to peripheral iNKT cells. 
Since IL-15Rα+ hematopoietic cells recover peripheral iNKT cells 
independent of thymic iNKT cell numbers, the role of DCs as a potential IL-
15 trans-presenting cell was investigated.  To examine the role of DCs in 
iNKT cell development and homeostasis, CD11c/IL-15Rα transgenic (Tg) 
mice (on an IL-15Rα-/- background) were utilized as a model where only DCs 
can trans-present IL-15 35. In these CD11c/IL-15Rα Tg mice, IL-15Rα+ DCs 
had little effect in recovering thymic NKT cell numbers leading to only a slight 
increase over that found in IL-15Rα-/- mice (FIGURE 18a and b).  
Interestingly, the loss of CD44HighNK1.1+ cells was the major developmental 
subset affected by the deficiency of IL-15Rα (FIGURE 18c).  In the liver, IL-
15Rα expression was most crucial compared to the other tissues as its 
absence resulted in the most dramatic iNKT cell deficiency (<90%) affecting 
both CD44High NK1.1- and NK1.1+ cells (FIGURE 18b and c).  Moreover, IL-
15Rα+ DCs significantly increased the frequency and absolute numbers of 
total CD1d-tetramer+, CD44High NK1.1-, and CD44High NK1.1+ cells (p<0.05) 
compared to IL-15Rα-/- mice (FIGURE 18a - c). The frequency and absolute 
numbers of splenic iNKT cells in Tg mice were increased compared to IL-
15Rα-/- mice but this increase was not significantly different (FIGURE 18b). 
As observed in the chimeras, no preferential effect was observed among 
either DN or CD4+ iNKT cell subsets (data not shown).  These data 
demonstrate that iNKT cells respond to DCs specifically in the peripheral  
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FIGURE 18. IL-15Rα+ DCs partially recover peripheral iNKT cells.  
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FIGURE 18. IL-15Rα+ DCs partially recover peripheral iNKT cells. A, 
Representative flow cytometric plots of CD1d-tetramer+ CD3+ cells in the 
thymus, liver and spleen of IL-15Rα-/- (left column), CD11c/IL-15Rα Tg 
(middle column) and WT (right column) mice. Plots are representative of 
three independent experiments. B, Absolute numbers of iNKT cells as 
detected by CD1d-tetramer were calculated for each group of mice, IL-15Rα-
/-
 (black bar), CD11c/IL-15Rα Tg (gray bar) and WT (white bar), in the 
respective tissues. Error bars represent S.E.M. and the numbers above bars 
represent percent of WT levels * p ≤ 0.05 (average of 3 independent 
experiments, n= 6/group). Tg and WT iNKT cell numbers were statistically 
compared against total iNKT from IL-15Rα-/- mice. C. graph shows the 
absolute numbers of iNKT subsets as determined by CD44 and NK1.1 
expression in the indicated mice. "This research was originally published 
in Blood Online. Eliseo F. Castillo, Luis F. Acero, Spencer W. Stonier, 
Dapeng Zhou, and Kimberly S. Schluns Thymic and peripheral 
microenvironments differentially mediate development and maturation 
of iNKT cells by IL-15 transpresentation Blood First Edition Paper, 
prepublished online June 25, 2010;DOI 10.1182/blood-2010-03-277103.”
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tissues indicating that thymic and peripheral iNKT cells respond to distinct IL-
15Rα+ cells depending on the tissue microenvironment.  
 
3.2.3 IL-15Rα+ DCs regulate proliferation and Bcl-2 levels in peripheral iNKT 
cells. 
iNKT cell numbers are dictated in part by proliferation and enhanced survival; 
therefore these parameters were examined as a means to investigate the 
mechanism for the increased iNKT cell numbers mediated by IL-15Rα+ DCs.  
Proliferation is believed to occur simultaneously with differentiation of 
CD44Low NK1.1- into CD44High NK1.1- iNKT cells and the maturation into 
CD44High NK1.1+ cells 90,107. To determine whether DCs drive the expansion 
of iNKT cells via IL-15 trans-presentation, all three groups of mice were 
treated with BrdU for 7 days and the BrdU incorporation of iNKT cells at the 
different developmental stages was analyzed (FIGURE 19a). Surprisingly, no 
significant differences in BrdU incorporation by iNKT cells from the three 
groups of mice were observed at any stage of iNKT cells in the thymus 
(FIGURE 19a). In contrast, BrdU incorporation by hepatic iNKT cells was 
congruent with the increase in peripheral iNKT cells observed in Tg and WT 
mice compared to IL-15Rα-/- mice (FIGURE 19a). This effect occurred 
regardless of NK1.1 expression suggesting that DC-mediated expansion was 
not restricted to a specific stage of differentiation or maturation (FIGURE 
19a). Overall, peripheral expansion of hepatic and splenic iNKT cells is 
mediated by DCs trans-presenting IL-15.  
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FIGURE 19. Proliferation and survival of peripheral iNKT cells are 
supported by DCs via IL-15 trans-presentation.   
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FIGURE 19. Proliferation and survival of peripheral iNKT cells are supported 
by DCs via IL-15 trans-presentation.   
A, graphs depict the percentage of BrdU+ iNKT subsets in the thymus, liver and 
spleen of IL-15Rα-/-, CD11c/IL-15Rα Tg, and WT mice after being given BrdU 
(0.8mg/ml) supplemented drinking water for 7 days. Subsets consisted of the 
various stages of iNKT cell development as defined by CD44 and NK1.1 
expression. Mean ± S.E.M. are shown and derived from 2 independent experiments 
(n=4 for IL-15Rα-/-, n=5 for CD11c/IL-15Rα Tg, n=4 for WT mice, *p ≤ 0.05). B, 
representative histograms comparing the levels of Bcl-2 expression from NK1.1+ 
subsets derived IL-15Rα-/- and CD11c/IL-15Rα Tg mice (top two panels) or 
CD11c/IL-15Rα Tg  and WT mice (bottom two panels) in the various tissues. C, the 
graph displays the mean fluorescence intensity of Bcl-2 from CD4+ or DN NK1.1+ 
subsets isolated from the thymus, liver and spleen of IL-15Rα-/-, CD11c/IL-15Rα Tg, 
WT mice. Mean ± S.E.M are shown and derived from 3 independent experiments 
(n= 6-8 mice/group, *p ≤ 0.05). "This research was originally published in Blood 
Online. Eliseo F. Castillo, Luis F. Acero, Spencer W. Stonier, Dapeng Zhou, 
and Kimberly S. Schluns Thymic and peripheral microenvironments 
differentially mediate development and maturation of iNKT cells by IL-15 
transpresentation Blood First Edition Paper, prepublished online June 25, 
2010;DOI 10.1182/blood-2010-03-277103.” 
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IL-15 up-regulates Bcl-2 expression and is one mechanism by which it 
increases cell survival 136.  In iNKT cells, Bcl-2 expression is also increased 
upon acquisition of NK1.1+ expression 110.  To determine whether DC-
mediated increases in iNKT cells correlated to Bcl-2 levels, Bcl-2 expression 
was examined in iNKT cells by quantitating the mean fluorescence intensity 
(MFI) of Bcl-2 via flow cytometry. In thymic iNKT cells, both CD4+ or DN 
NK1.1+ cells from WT mice expressed significantly higher levels of Bcl-2 than 
the analogous subsets from either IL-15Rα-/- and Tg mice (FIGURE 19b and 
c). In the liver, Bcl-2 expression in CD4+ and DN iNKT cells from the Tg mice 
was significantly higher (p< 0.05) than the same cells from IL-15Rα-/- mice 
and was quite comparable to that seen in WT mice (FIGURE 19b and c).  In 
splenic iNKT cells, Bcl-2 had a hierarchal expression among IL-15Rα-/-
<Tg<WT mice; however, this trend was not statistically significant (FIGURE 
19b and c). In general, these findings suggest that reduced numbers of iNKT 
cells observed in the thymus of IL-15Rα-/- and Tg mice are due to decrease 
numbers of CD44High NK1.1+ iNKT cells resulting in part by reduced Bcl-2 but 
not defective proliferation.  In the periphery, particularly in the liver, the partial 
restoration of iNKT cells in the Tg mice is mediated by DCs trans-presenting 
IL-15, which affect both the proliferation and survival of iNKT cells during late 
development.  
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3.2.4 Homeostatic proliferation of iNKT cells is mediated by DCs via IL-15 
trans-presentation. 
Similar to memory CD8 T cells, the homeostasis of mature iNKT cells is 
mediated by basal proliferation and is similarly dependent on IL-15 34,111; 
however, the cell-type mediating this event for iNKT cells has not been 
elucidated. To assess the role of IL-15Rα+ DCs in regulating iNKT cell 
homeostasis, mature iNKT cells (>94% CD44HighNK1.1+) were enriched from 
the thymus of WT mice (CD45.1+), CFSE-labeled, and transferred to IL-
15Rα-/-, Tg, and WT mice (all CD45.2+). Seven days after transfer, donor-
derived CD1d-tetramer+ cells were detected in the spleen and liver, but not 
the thymus of all mice.  Among the different tissues, the liver was the major 
site of iNKT cell homeostatic proliferation.  As expected, very little cell 
division of iNKT cells was observed upon transfer into IL-15Rα-/- hosts while 
a low level of proliferation was observed in WT hosts (FIGURE 20a).  Upon 
transfer into Tg mice, iNKT cells underwent a similar level of proliferation as 
that in WT hosts indicating that the presence of IL-15Rα+ DCs was sufficient 
for iNKT cell proliferation (FIGURE 20a). Furthermore, the number of donor 
iNKT cells found in the liver was completely restored by the presence of IL-
15Rα+ DCs while decreased in IL-15Rα-/- mice (FIGURE 20b). Interestingly, 
the maintenance of iNKT cells in the spleen did not depend on IL-15Rα 
expression (FIGURE 20b).  These findings demonstrate that DCs are a 
major cell-type providing IL-15 in the liver for homeostatic proliferation.  
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FIGURE 20. IL-15Rα+ DCs drive the homeostatic proliferation of mature 
iNKT cells. 
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FIGURE 20. IL-15Rα+ DCs drive the homeostatic proliferation of mature 
iNKT cells. iNKT cells enriched from the thymus of WT congenic (CD45.1) 
mice were labeled with CFSE and then transferred to congenic (CD45.2) IL-
15Rα-/-, CD11c/IL-15Rα Tg and WT mice. Seven days after the transfer, 
mice were sacrificed to assess the recovery and CFSE dilution of donor cells 
in the various tissues of the three groups of mice. A, dilution of CFSE by 
donor iNKT cells (CD45.1+) found in the spleen and liver seven days after the 
adoptive transfer into congenic CD45.2+ IL-15Rα-/-, CD11c/IL-15Rα Tg and 
WT mice. B, graph shows the absolute number of donor iNKT cells (gated on 
CD45.1+ CD1d-tetramer+ cells) recovered in the liver and spleen seven days 
after the adoptive transfer into the three groups of mice. Horizontal bar is the 
average of 3 independent experiments (n=5-7 mice/group, * p<0.001). "This 
research was originally published in Blood Online. Eliseo F. Castillo, 
Luis F. Acero, Spencer W. Stonier, Dapeng Zhou, and Kimberly S. 
Schluns Thymic and peripheral microenvironments differentially 
mediate development and maturation of iNKT cells by IL-15 
transpresentation Blood First Edition Paper, prepublished online June 
25, 2010;DOI 10.1182/blood-2010-03-277103.”
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3.2.5 IL-15 is important for functional maturation of IFN-γ producing hepatic 
iNKT cells. 
A distinguishing feature of iNKT cells is their ability to rapidly produce IFN-γ 
upon stimulation with αGalCer 87. Therefore, to assess the functional 
responsiveness of iNKT cells in vivo, IFN-γ expression by iNKT cells was 
analyzed 2.5 hrs after i.v injection of αGalCer in the various mice (IL-15Rα-/-, 
Tg, and WT). Previous studies have reported that thymic iNKT cells in normal 
mice do not express IFN-γ in response to αGalCer 87. This finding was also 
found to be true in my hands (data not shown). In the liver, few iNKT cells 
produced IFN-γ in IL-15Rα-/- mice while a significant proportion of iNKT cells 
expressed IFN-γ in response to αGalCer in Tg and WT mice (FIGURE 21a 
and b). Interestingly, iNKT cells in the spleen of all three groups of mice 
produced IFN-γ after αGalCer stimulation, albeit, the percent of iNKT cells 
producing IFN-γ in IL-15Rα-/- mice was significantly reduced compared to WT 
and Tg mice (FIGURE 21b).  This finding demonstrates that functional 
maturation of splenic iNKT cells is not heavily dependent on IL-15Rα and 
therefore may be mediated by other factors. IL-4 was also expressed by 
iNKT cells at low levels after αGalCer stimulation but was not affected by IL-
15Rα expression (data not shown).  Nevertheless, functional maturation of 
hepatic iNKT cells is critically dependent on IL-15 signaling, which can be 
provided by DCs.   
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FIGURE 21. IL-15 signaling optimizes T-bet induced gene products in 
iNKT cells. 
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FIGURE 21. IL-15 signaling optimizes T-bet induced gene products in iNKT 
cells. iNKT cells were activated by administering αGalCer to each group of mice. 
iNKT cells from the liver and spleen were analyzed for IFN-γ production (2.5 hrs 
later) via intracellular cytokine staining. Representative histograms showing the 
percent of hepatic (A) and splenic (B) iNKT cells producing IFN-γ after αGalCer 
administration from treated mice (IL-15Rα-/-, Tg, and WT mice) and untreated WT 
mice (negative control). The graph shows the average percent of IFN-γ+ iNKT cells 
from the liver (A) and spleen (B) from all treated groups. Error bars represent 
S.E.M. and is combined data from two independent experiments, n= 4-5 
mice/group, *p ≤ 0.005. C, flow cytometric plots displaying CD44 and T-bet 
expression in CD1d-tetramer+ cells from the thymus and liver of IL-15Rα-/- and WT 
mice. Upper right graph shows the percentage of T-bet+ iNKT cells from the thymus 
and liver of the two groups (*p<0.0005). Lower right graph shows average MFI of T-
bet expression in CD44HighNK1.1+ iNKT cells from IL-15Rα-/- and WT mice isolated 
from the thymus and liver (*p<0.0001). D, representative histogram of CD122 
expression in thymic CD44+NK1.1+ iNKT cells from IL-15Rα-/- and WT mice and the 
graph displays the average MFI of CD122 expression from both groups 
(*p<0.0001). Fig 4C-D combined data from two independent experiments, n=6 for 
both IL-15Rα-/- and WT mice. Error bars represent S.E.M. "This research was 
originally published in Blood Online. E.F. Castillo et al., Thymic and peripheral 
microenvironments differentially mediate development and maturation of 
iNKT cells by IL-15 transpresentation. Blood First Edition Paper, prepublished 
online June 25, 2010;DOI 10.1182/blood-2010-03-277103.” 
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The low level of IFN-γ expression in IL-15Rα-/- iNKT cells after αGalCer 
stimulation suggests these cells are functionally immature or unprimed. The 
transcription factor, T-bet, drives the functional maturation of iNKT cells by 
regulating the expression of several genes including CD122 and IFN-γ 59,116. 
Therefore, T-bet expression was analyzed in iNKT cells from both IL-15Rα-/- 
and WT mice via flow cytometry. Since iNKT cells in thymus and liver are 
heavily dependent on IL-15Rα, we specifically analyzed iNKT cells from 
these two tissues (FIGURE 21c).  Although T-bet was expressed by IL-15Rα-
/-
 iNKT cells, only 59% and 47% of the population expressed high levels of T-
bet in the thymus and liver, respectively, which was significantly less than the 
observed among iNKT cells in the thymus (96%) and liver (89%) of WT mice 
(FIGURE 21c). High T-bet expression was relevant as IFN-γ expression was 
restricted to this population (data not shown).  Among CD44High NK1.1+ iNKT 
cells, the level of T-bet expression was significantly reduced in both the 
thymus and liver, but not spleen, of IL-15Rα-/- mice indicating the overall, 
reduced T-bet was not just due to disproportional subsets of developing iNKT 
cells (FIGURE 21c, data not shown). In addition to T-bet, CD122 expression 
by thymic CD44High NK1.1+ iNKT cells was notably reduced in IL-15Rα-/- mice 
(FIGURE 21d).  Although T-bet and CD122 are both reduced in the absence 
of IL-15Rα, double staining for CD122 and T-bet was unable to directly 
demonstrate a correlation in expression, which may be an indication that T-
bet is not the only regulator of CD122.  Thus, the reduced number of IFN-γ+ 
iNKT cells responding to αGalCer stimulation in IL-15Rα-/- mice suggests 
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these iNKT cells are not fully functional, which could be due in part to the 
lack of IL-15-mediated expression of T-bet and/or CD122.  
 
3.2.6 IL-15/IL-15Rα complex enhances IFN-γ and T-bet expression in IL-
15Rα-/- iNKT cells.  
The above observations suggest IL-15 contributes to the functional 
maturation of iNKT cells. To determine if IL-15 signaling could recover the 
defect observed in the absence of IL-15Rα, IL-15Rα-/- mice were treated with 
IL-15/IL-15Rα complex.  Past studies have shown IL-15/IL-15Rα complex 
provides a potent IL-15 signal independent of trans-presentation 137 and does 
not influence the production of IFN-γ by iNKT cells 138. Since the activity of 
the complex declines considerably within 24 hrs 137, possible effects of IL-15 
stimulation on maturation can be separated from those during activation by 
stimulating mice with αGalCer 2 days after the initial IL-15 treatment. 
Accordingly, IL-15Rα-/- mice were pretreated with the IL-15/IL-15Rα complex, 
then injected i.v. with αGalCer followed by analysis of IFN-γ expression 2.5 
hrs later. Interestingly, pretreatment with IL-15/IL-15Rα significantly amplified 
the percentage of hepatic iNKT cells expressing IFN-γ in response to 
αGalCer compared to those iNKT cells in IL-15Rα-/- mice not receiving a prior 
IL-15 signal (FIGURE 22a). Pretreatment with IL-15/IL-15Rα also increased 
the expression of IFN-γ in splenic iNKT cells; however this effect was not 
statistically significant (FIGURE 22b). This recovery in IFN-γ expression by  
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FIGURE 22. Pretreatment with IL-15/IL-15Rα complex restores iNKT cell 
responses in IL-15Rα-/- mice. 
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FIGURE 22. Pretreatment with IL-15/IL-15Rα complex restores iNKT cell 
responses in IL-15Rα-/- mice. Analysis of iNKT cells producing IFN-γ after 
αGalCer administration in IL-15Rα-/- mice pretreated with or without IL-15/IL-
15Rα complex. A, representative histogram overlaying the percent of hepatic 
iNKT cells producing IFN-γ from treated and untreated IL-15Rα-/- mice. B, 
graph shows the average percent of iNKT cells in the liver and spleen 
expressing IFN-γ in response to αGalCer in mice either pretreated or 
untreated with IL-15/IL-15Rα complex. C and D, effect of IL-15 signaling on 
T-bet expression in IL-15Rα deficient mice.  IL-15/IL-15Rα complex was 
injected into IL-15Rα-/- mice and one day later, T-bet expression in iNKT cells 
was analyzed by flow cytometry. C, representative histogram displaying an 
overlay of the level of T-bet expressed in CD1d-tetramer+ CD44HighNK1.1+ 
cells isolated from liver of treated and untreated IL-15Rα-/- mice. D, combined 
data presenting the average MFI of T-bet in CD44HighNK1.1+ iNKT cells from 
the liver of IL-15/IL-15Rα complex treated or untreated mice. Graphs shown 
in B and D are generated from two independent experiments, n=4 mice. 
Error bars represent S.E.M., *p<0.05. "This research was originally 
published in Blood Online. Eliseo F. Castillo, Luis F. Acero, Spencer W. 
Stonier, Dapeng Zhou, and Kimberly S. Schluns Thymic and peripheral 
microenvironments differentially mediate development and maturation 
of iNKT cells by IL-15 transpresentation Blood First Edition Paper, 
prepublished online June 25, 2010;DOI 10.1182/blood-2010-03-277103.”
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IL-15/IL-15Rα pretreatment supports the notion that IL-15 primes hepatic 
iNKT cells for IFN-γ production.  
 
To determine if the IL-15 signals affect the key regulator in iNKT functional 
maturation, T-bet was analyzed in IL-15Rα-/- mice treated with just the IL-
15/IL-15Rα complex.  A day after injection of the IL-15/IL-15Rα complex, 
hepatic CD44High NK1.1+ iNKT cells had a significant increase in T-bet 
expression when compared to the corresponding population in untreated IL-
15Rα-/- mice (FIGURE 22c and d). So, although T-bet expression is low in 
iNKT cells in IL-15Rα-/- mice, encountering IL-15 in vivo increases the level of 
T-bet expression in mature iNKT cells. Collectively, this data demonstrates 
IL-15 signaling not only boost iNKT cells ability to produce IFN-γ in response 
to αGalCer but also augments T-bet expression.  
 
3.2.7 IL-15 trans-presentation in periphery promotes functional 
responsiveness in vivo. 
As previously mentioned, thymic iNKT do not respond to αGalCer in vivo 87; 
however, thymic and hepatic iNKT cells express IFN-γ to a similar degree 
when stimulated with αGalCer in the presence of DCs 103. Therefore, we 
asked if thymic iNKT cells become functionally responsive in a different in 
vivo tissue microenvironment and whether this is dependent on IL-15Rα 
expression.  Therefore, iNKT cells were enriched from the thymus of WT 
(CD45.1) mice, adoptively transferred into WT or IL-15Rα-/- (CD45.2) mice  
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FIGURE 23. Thymic iNKT cells respond to αGalCer in the periphery in 
the presence of IL-15Rα.  
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FIGURE 23. Thymic iNKT cells respond to αGalCer in the periphery in 
the presence of IL-15Rα.  iNKT cells were enriched from the thymus of 
congenic (CD45.1) WT mice and transferred into a congenic (CD45.2) WT 
host to seed the periphery. Two days after the cell transfer, mice were 
injected with αGalCer to activate iNKT cells in vivo. A. Representative 
histogram showing the level of IFN-γ being produced by donor (open 
histogram) and resident iNKT cells (shaded histogram) in liver of mice which 
received αGalCer two days after the adoptive transfer. B, bar graph of the 
combined data of IFN-γ+ donor (white bars) and resident (gray bars) iNKT 
cells isolated from the liver or spleen of mice stimulated with αGalCer in vivo. 
Data is generated from two independent experiments (n=4), C, bar graph of 
the combined data of donor IFN-γ+ iNKT cells isolated from the liver of IL-
15Rα-/- (white bar) and WT (gray bars) mice. Data are generated from three 
independent experiments (n=6 for IL-15Rα-/- host and n=4 for WT host). Error 
bars represent S.E.M., *p<0.05. "This research was originally published 
in Blood Online. Eliseo F. Castillo, Luis F. Acero, Spencer W. Stonier, 
Dapeng Zhou, and Kimberly S. Schluns Thymic and peripheral 
microenvironments differentially mediate development and maturation 
of iNKT cells by IL-15 transpresentation Blood First Edition Paper, 
prepublished online June 25, 2010;DOI 10.1182/blood-2010-03-277103.”
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and then analyzed for IFN-γ expression in response to αGalCer.  In WT mice, 
donor thymic iNKT cells became responsive to αGalCer in the liver and 
spleen; however, the donor iNKT cells were not as responsive as the 
resident iNKT cells (FIGURE 23a and b).  In addition, IFN-γ expression by 
donor iNKT cells was increased in the spleen compared to the liver (FIGURE 
23a and b).  In the absence of host IL-15Rα, the percent of iNKT cells 
expressing IFN-γ in response to αGalCer was further decreased to a 
significant degree (FIGURE 23c) suggesting IFN-γ responses in the liver 
were dependent on IL-15Rα.  Collectively, these results suggest that 
encountering IL-15 in the periphery promotes and enhances the ability of 
iNKT cells to express IFN-γ in response to stimulation, thus highlighting an 
important role for IL-15 in iNKT cell maturation and activation.   
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3.3 Discussion 
Preferences in cell-specific IL-15 trans-presentation by hematopoietic or non-
hematopoietic cells have been shown for memory CD8+ T cells, NK cells, 
and iIELs, but not for iNKT cells 29,135.  Moreover, while IL-15 has a clear role 
in iNKT cell development and homeostasis 13,34,111, the role of IL-15 trans-
presentation in these processes had not been previously investigated.  
Herein, I show the cell-type trans-presenting IL-15 to iNKT cells as well as 
the function of IL-15 was dependent on the tissue site.  Furthermore, I 
revealed a new role for IL-15 in the functional maturation and activation of 
iNKT cells. Taken together, my work highlights how IL-15 regulates the 
development, functional maturation, and homeostasis of iNKT cells through 
multiple mechanisms, which are mediated by distinct cell types in a tissue-
specific fashion.   
 
IL-15 is capable of mediating differentiation, proliferation, and survival; 
however, the role of IL-15 on iNKT cells was different between tissues.  In 
the thymus, IL-15 trans-presentation was essential for survival but not so 
much for the expansion of developing iNKT cells.  Other studies have found 
CD28/B7 and ICOS/B7h co-stimulation drives intrathymic iNKT cell 
expansion 139. Thus, the proliferation observed in thymus of IL-15Rα-
deficient mice could be due to co-stimulation and other γC cytokines. In 
contrast to the thymus, IL-15 influenced both the proliferation and survival of 
iNKT cells in the periphery. My finding of IL-15-mediated proliferation is in 
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contrast to the lack of proliferation of iNKT cells observed in IL-15 Tg mice 
140
.  In this IL-15 Tg model, the excess IL-15 produced likely binds to the 
many cell types expressing IL-15Rα, which do not normally trans-present IL-
15.  Therefore, situations of excess IL-15 may yield different outcomes 
because IL-15 is not provided by specific cell types.  I provide evidence that 
IL-15 regulates cell survival as peripheral iNKT cells displayed reduced levels 
of Bcl-2 and were not sustained in IL-15Rα-/- mice.  While IL-15 notoriously 
drives proliferation of mature CD44High NK1.1+ cells 34, I found the presence 
of IL-15Rα also increased the proliferation of immature hepatic CD44High 
NK1.1- cells.  Since proliferation of immature CD44High NK1.1- cells was 
modulated by IL-15 in the liver but not in the thymus, it suggests that the type 
of IL-15 response is better dictated by the microenvironment than the stage 
of differentiation.   
 
In contrast to the thymus and liver, splenic iNKT cells in IL-15Rα-/- mice were 
only minimally deficient in numbers and responded well to αGalCer.  
Altogether, these findings could suggest that another factor is substituting for 
IL-15 in the spleen.  As IL-7 shares many of the same signals as IL-15 and 
has been shown to be important for splenic iNKT cells 34, I think IL-7 is a 
good candidate.  Interestingly, as IL-15 is provided to other cell types in the 
spleen, it is unclear why splenic iNKT cells do not assess these IL-15-
producing cells.  I speculate other mechanisms determine the niche where 
specific cells reside in or mediate specific cell-cell interactions. Alternatively, 
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iNKT cells in the spleen and liver may be distinct populations that have 
obtained differential requirements for the respective cytokines. 
 
It is often assumed that the function of IL-15 in lymphocyte development and 
homeostasis is to induce survival and proliferation; however, my analyses of 
iNKT cell responses provide evidence that the functions of IL-15 go beyond 
regulating cell numbers.  Somewhere along the developmental pathway, 
iNKT cells acquire the ability to rapidly respond to TCR stimulation by 
producing both IL-4 and IFN-γ. As IL-4 and IFN-γ expression are regulated by 
Gata-3 and T-bet, respectively, the expression of these transcription factors 
is important for functional maturation of iNKT cells 116.  Therefore, it was 
interesting to find that T-bet expression was decreased in iNKT cells in IL-
15Rα-/- mice.  While this could be due to a preferential loss of T-bet+ cells, T-
bet was up-regulated in a short term response to IL-15.     
 
More importantly, the ability of iNKT cells to express IFN-γ in response to 
αGalCer was virtually lost in IL-15Rα-/- mice but restored by prior exposure to 
IL-15.  In Th1 cells, signaling through the γC subunit via IL-2 revealed the 
JAK3/STAT5 pathway is required for IFN-γ production 141.  Essentially, 
STAT5 grants T-bet access to the IFN-γ promoter region by promoting 
chromatin accessibility.  As IL-15 and IL-2 both utilize the same receptor 
subunits and signaling (JAK3/STAT5) pathway, IL-15 could be the 
physiological factor activating STAT5 in iNKT cells rather than IL-2.  
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Additionally, since repetitive administration with αGalCer impairs IFN-γ 
production in iNKT cells 142,143, it would be interesting to investigate whether 
IL-15/IL-15Rα treatment can reverse this defect.  Overall, my findings 
suggest that IL-15 is important for promoting IFN-γ production in iNKT cells 
and therefore treatment of IL-15/IL-15Rα prior to αGalCer might generate a 
more potent IFN-γ response. 
 
I noted the function of IL-15 during iNKT cell development varied in different 
tissue microenvironment, which may be credited to the cell-type trans-
presenting IL-15. DCs, macrophages, and thymic stromal cells are all present 
and capable of trans-presenting IL-15 in the thymus; however, despite this, 
thymic iNKT cells respond only to IL-15 in the non-hematopoietic 
compartment, again supporting the idea that the niches or cell-cell 
interactions are tightly regulated. Medullary thymic epithelial cells are likely 
the non-hematopoietic cell-type trans-presenting IL-15 to iNKT cells as prior 
studies found that RelB-deficient mice lack normal medullary thymic epithelial 
cells, have defective iNKT cell development, and reduced levels of IL-15 
transcript 119,120. Surprisingly, despite our finding that non-hematopoietic 
expression of IL-15Rα was completely sufficient to restore iNKT cell numbers 
in the thymus, a deficiency in iNKT cells in the liver was still apparent.   
 
Moreover, a complete deficiency of iNKT cells in the thymus did not translate 
to a major deficiency in either the liver or the spleen.  This demonstrates the 
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unappreciated importance of post-thymic development and maturation and 
illustrates the dependence on the peripheral microenvironment for 
completing development and maintaining mature iNKT cells.  
 
Unlike thymic iNKT cells, peripheral iNKT cells receive IL-15 trans-presented 
by either hematopoietic or non-hematopoietic cells. Here, I identify DCs as a 
major cell-type regulating Bcl-2 and mediating homeostatic proliferation while 
having less of an impact on total cell numbers; this could be indicative that 
DCs have a more minor role in late post-thymic expansion and more 
important role in homeostasis.  More surprisingly, DCs were able to restore 
functional maturation of iNKT cells in the liver, thus identifying a new role for 
DCs in iNKT cell biology.  This ability to induce IFN-γ expression in iNKT 
cells may provide another mechanism by which DCs dictate the fate of an 
immune response.  IL-15Rα BM chimeras also revealed hepatic iNKT cell 
numbers were controlled by IL-15Rα+ non-hematopoietic cells, which are 
likely hepatic stellate cells (Ito cells) 121. It would be interesting to determine 
whether Ito cells are also capable of promoting functional maturation.    
 
Regarding IL-15Rα expression by iNKT cells, a recent study revealed 
RelA/NF-κB controls IL-15 signaling in iNKT cells by enhancing IL-15Rα 
expression in iNKT cells 117. In support of iNKT cells responding to IL-15 
through the IL-15Rαβγ heterotrimeric complex, IL-15Rα-/- mice lack iNKT 
cells 21. Thus, the phenotype of IL-15Rα-/- mice and the role of RelA in IL-
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15Rα expression makes it plausible that iNKT cells can respond to IL-15 
through the IL-15Rαβγ heterotrimeric complex. Although this hypothesis is 
possible, my data using BM chimeras demonstrates that IL-15Rα expression 
by iNKT cells is unnecessary for the generation of iNKT cells. Future work 
should address if IL-15Rα expression by iNKT cells is linked to Axl or 
NKG2D signaling as these molecules have been shown to associate with IL-
15Rα or the IL-15 signaling pathway, respectively 144,145.” 146 
In conclusion, I have identified the cell-types regulating the development and 
homeostasis of iNKT cells via IL-15 trans-presentation in the various tissue 
microenvironments where iNKT cell reside.  
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CHAPTER 4 
 
CONCLUSIONS AND DISCUSSION 
 
4.1 Summary of Chapter 2. 
4.1.1 The source of IL-15 during NK cell development and homeostasis.  
Prior studies investigating the role of IL-15Rα expression by hematopoietic and 
non-hematopoietic cells provided the first clues that multiple diverse cell-types could 
trans-present IL-15 to NK cells 29. My data support these prior reports and extends 
on these findings by revealing both compartments trans-present IL-15 but at 
different developmental stages. Thus, the maturation status of NK cells dictates the 
cell-type trans-presenting IL-15. Also, it was previously thought non-hematopoietic 
cells were the primary source of IL-15; however, this report reveals for the first time 
the hematopoietic compartment is the major source of IL-15 during NK cell 
development and homeostasis.  
 
NK cells become dependent on IL-15 early during development. The earliest 
population committed to the NK cell lineage is NKp’s; however, this CD122-
expressing population is not dependent on IL-15. The transition of NKp’s to 
immature NK cells marks their dependency on IL-15 48. By actually examining the 
NK cell stages recovered by the various cellular IL-15Rα+ compartments, I find this 
only partially true. Immature NK cells can be separated into two states based on 
Ly49 expression. The Ly49- population, like NKp’s, develops in the absence of IL-
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15. Upon the acquisition of Ly49 receptors, NK cells become reliant on IL-15. In the 
BM and liver, both cellular compartments are equally important in providing IL-15 at 
this stage of development. In the spleen, the hematopoietic compartment is the 
dominant source of IL-15 to generate this population. Interestingly, IL-15 trans-
presentation by the hematopoietic compartment emerges as the more efficient 
population to drive Ly49 expression by NK cells 67.  
 
The transition to become functionally mature NK cells comes after acquiring the 
various Ly49 activating and inhibitory receptors. Like immature counterparts, mature 
NK cells can be separated into two separate stages based on DX5 and CD11b 
expression. The M1 (DX5+ CD11bLow) population is found in the BM, LV, and SP 
and the presence of M1 NK cells in each of these tissues is contingent on 
hematopoietic cells providing IL-15. The M2 (DX5+ CD11bHigh) NK cells, which are 
derived from M1 NK cells, are even more dependent on IL-15 trans-presentation by 
hematopoietic cells in each of these tissues. Although, the non-hematopoietic 
compartment can partially recover both populations of mature NK cells, mature NK 
cells are more likely to interact with hematopoietic cells at this stage of 
development.  
 
This “division of labor” by both cellular compartments is likely due to the cell-cell 
interaction and the exact location of NK cells in the tissue microenvironment. It 
could be envisioned NKp’s and Ly49- immature NK cells are in the same location as 
BM stroma where they begin to see IL-15. In this niche, NKp’s differentiate into 
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Ly49- NK cells through as yet undetermined mechanism that is independent of IL-
15. Additionally, the Ly49- NK cells respond to IL-15 and differentiate into Ly49+ NK 
cells. This population is dependent on IL-15 and probably vacates the stromal niche 
to acquire IL-15 from a different cellular source (i.e. hematopoietic cells) and to 
provide space for progenitor cells (i.e. NKp’s and Ly49- NK cells). Once out of the 
BM stroma niche, NK cell further differentiate by responding to hematopoietic cell-
mediated IL-15 trans-presentation. This “division of labor” model is depicted in 
FIGURE 24. These same events likely occur in the liver given that this tissue 
microenvironment contains cells from both cellular compartments capable of 
producing IL-15. On the contrary, the spleen contains far more hematopoietic cells 
than non-hematopoietic cells; hence, a more dominant requirement of IL-15 being 
provided by hematopoietic cells for splenic NK cells. In conclusion, the cell-type 
trans-presenting IL-15 is dependent on the composition of cells in the tissue site 
and the level of NK cell maturity. 
 
4.1.2 The function of IL-15 during NK cell development and homeostasis. 
IL-15 is known to influence multiple cellular functions including proliferation and 
survival. Past reports have shown IL-15 is crucial for NK cell survival by regulating 
the anti-apoptotic molecules, Bcl-2 and Mcl-1 69,72. IL-15 can also expand NK cells 
in vitro; however, the primary in vivo role of IL-15 during NK cell development and 
homeostasis is thought to mediate survival (via Bcl-2 and Mcl-1) since the adoptive 
transfer of CFSE-labeled NK cells into IL-15-/- and WT mice have a similar CFSE  
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FIGURE 24. Regulation of NK cell development. 
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FIGURE 24. Regulation of NK cell development. 
An illustrative model is shown depicting the various hematopoietic and non-
hematopoietic cell-types trans-presenting IL-15 to immature and mature NK cells. 
Briefly, NKp’s and Ly49- NK cells (both IL-15-independent populations) are 
surrounded by the BM stromal niche. Both stromal cells and hematopoietic cells 
(e.g. DCs and macrophages) trans-present IL-15 to the Ly49- NK cells which then 
differentiate into Ly49+ NK cells and become IL-15 dependent. This population 
leaves this “niche” (through an unknown mechanism but possibly mediated by IL-
15) to allow further occupancy by NKp’s and Ly49- NK cells. The Ly49+ NK 
population then occupies a “hematopoietic niche” that includes DCs and 
macrophages where NK cells then differentiate into mature NK cells.  
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profile. Nevertheless, I have found IL-15 is critical for the proliferation of mature NK 
cells in the BM but not in the periphery. This IL-15-independent proliferation 
observed in the periphery may be due to the cellular niche, constraints on IL-15-
mediated cellular expansion or other factors regulating proliferation. For instance, 
both NK and iNKT cells reside in high numbers in the liver but differences in BrdU 
incorporation was observed for both cell-types in IL-15Rα-/- and WT mice. In hepatic 
NK cells, the incorporation of BrdU by NK cells was similar in both IL-15Rα-/- and 
WT mice whereas hepatic iNKT cells in IL-15Rα-/- mice had a significant decrease 
in BrdU incorporation in comparison to WT iNKT cells. Thus, the cellular niche may 
influence the function of IL-15 in the various IL-15-dependent populations. 
 
Additionally, I revealed IL-15 regulates NK cell differentiation at two different levels 
of development. The first differentiation event regulated by IL-15 is the acquisition of 
the various Ly49 receptors. A past report had hinted at the notion of IL-15 regulating 
Ly49 expression but the interpretation of that study suggested IL-15Rα expression 
by NK cells was crucial in this differentiation process 67.  Using mixed BM chimeras, 
I have completely ruled out the notion that IL-15Rα expression by NK cells is 
required for the induction of the Ly49 repertoire. In human NK cells, IL-15 has also 
been shown to regulate KIR expression via the transcription factor, c-myc 133. Other 
transcription factors (Gata-3 and Runx1) have also been shown to regulate Ly49 
receptors in murine NK cells 55,58. Thus, it is crucial to decipher the transcriptional 
network regulating both activating and inhibitory Ly49 receptor expression and what 
role, if any, IL-15 has in regulating these transcription factors. 
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The second differentiation event regulated by IL-15 is the transition of mature 
CD11bLow NK cells into CD11bHigh NK cells. This differentiation event is very 
dependent on IL-15 trans-presentation by hematopoietic cells. Recently, it was also 
shown IL-15Rα expression by either DCs or macrophages contributes to the 
generation of CD11bHigh NK cells 122. Interestingly, the effector function of CD11bHigh 
NK cells is greater than that of CD11bLow NK cells 47. Thus, it could be speculated 
that NK cell functional maturation occurs during this cellular differentiation. Since IL-
15 induces effector functions and the transcription factors, MEF and CEBP-γ, 
 regulate effector function, IL-15 may regulate MEF and CEBP-γ 61,62.  
 
With regards to IL-15 regulating Ly49 expression, could NK cell “education” be co-
dependent on IL-15? This role is plausible since IL-15 signaling assist in the up-
regulation of Ly49 receptors and can activate NK cells 73. What's more, transgenic 
expression of Bcl-2 in IL-15Rβ-deficient mice recovered NK cell numbers but did not 
recover the cytolytic activity of rescued NK cells suggesting IL-15Rβ signaling is 
important for functional maturation 69. Moreover, IL-15Rα and MHC class Ia are 
expressed by both hematopoietic and non-hematopoietic cells which would enable 
either cell-type the ability to trans-present IL-15 and interact with the numerous 
Ly49 receptors. Collectively, this hints at a possible role of IL-15 signaling in the 
education of NK cells. Thus, it could be hypothesized that during IL-15 trans-
presentation by an IL-15Rα+ cell (hematopoietic or non-hematopoietic), NK cell 
‘education’ or the preparation thereof may take place, a concept previously thought 
to be mediated by MHC class Ia and an unknown activating signal.  
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4.1.3 Conclusion. 
In summary, I have revealed IL-15 trans-presentation by DCs contributes to the in 
vivo development and maintenance of functionally mature NK cells. My data 
highlight an important concept that the developmental and homeostatic niche of NK 
cells is not only driven by IL-15 but by distinct IL-15Rα+ cell-types that may be tightly 
regulated by the tissue microenvironment. This understanding of IL-15 trans-
presentation by specific IL-15Rα+ cell-types can assist in the quest to restore, 
maintain, or differentiate NK cells after adoptive transfer or BM transplantation. 
Thus, the identification of the cell-types and the regulation of IL-15 trans-
presentation by these cell-types may offer an invaluable tool that will allow for the 
manipulation of NK cells in vivo.  
 
4.2 Summary of Chapter 3. 
4.2.1 The source of IL-15 during iNKT cell development and homeostasis. 
IL-15 has been shown to be critical for the development and homeostasis of iNKT 
cells; however, the cell-type providing IL-15 to iNKT cells was unknown. 
Nevertheless, preliminary studies analyzing the cell-type trans-presenting IL-15 to 
NK1.1+ T cells provided the first clues that both hematopoietic and non-
hematopoietic compartments are crucial for iNKT cells 29. Naturally, my experiments 
investigating IL-15 trans-presentation by hematopoietic and non-hematopoietic cells 
for invariant NKT cells revealed both compartments are equally important. 
Surprisingly, the tissue microenvironment dictated which cell-type was trans-
presenting IL-15 to iNKT cells as depicted in FIGURE 25.  
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Briefly, the cell-type providing IL-15 to iNKT cells in the thymus was strictly of non-
hematopoietic origin. A likely candidate is the IL-15-producing medullary thymic 
epithelial cells (mTEC). Although hematopoietic cells are present in the thymus they 
appear to have no role in maintaining thymic iNKT cells. This is likely due to various 
developmental events directing iNKT cells to a certain anatomical location in the 
thymus. In the thymus, the CD44High NK1.1+ iNKT cells are dependent on IL-15 34. 
This population of iNKT cells expresses CXCR3 which is actively involved in the 
retention of iNKT cells in the thymus 116. mTECs have been shown to produce 
CXCR3 ligands which consequentially will retain iNKT cells in the thymic medullary 
epithelium. Therefore, the dynamics of the tissue microenvironment and the events 
occurring during iNKT cell development control the cell-type trans-presenting IL-15 
to thymic iNKT cells. 
 
Unlike thymic iNKT cells, peripheral iNKT cells can receive IL-15 trans-presented by 
either hematopoietic or non-hematopoietic cells. In this study, I have identified DCs 
as a major hematopoietic cell-type involved in hepatic iNKT cell homeostasis. The 
interaction of iNKT cells with DCs are likely due to both cell-types being in the same 
anatomical location. Specifically in the liver, both cells are found in the liver 
sinusoids so their interaction can be anticipated 147. IL-15Rα BM chimeras also 
revealed hepatic iNKT cell numbers were controlled by IL-15Rα+ non-hematopoietic 
cells, which are likely hepatic stellate cells (Ito cells). Similar to DCs, Ito cells can 
produce IL-15 and have been shown to drive the homeostatic proliferation of  
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FIGURE 25. Regulation of iNKT cell development. 
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FIGURE 25. Regulation of iNKT cell development. 
An illustrative model is shown depicting the various hematopoietic and non-
hematopoietic cell-types trans-presenting IL-15 to developing iNKT cells in the 
thymus and periphery. In the thymus, medullary thymic epithelial cells trans-present 
IL-15 to stage 3 (CD44HighNK1.1+) iNKT cells that have migrated to the thymic 
medullary epithelium. In the liver, both hematopoietic (DCs) and non-hematopoietic 
(Ito cells) compartments can trans-present IL-15 to stage 2 (CD44HighNK1.1-) and 
stage 3 (CD44HighNK1.1+) iNKT cells. 
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hepatic iNKT cells 121. Ito cells are also situated in the liver sinusoids thus, capable 
of interacting with iNKT cells 121. The presence of DCs and Ito cells in close 
proximity to hepatic iNKT cells provide likely clues on why this tissue site is so rich 
for iNKT cells and dependent on both cellular compartments for IL-15. So although 
thymic and hepatic iNKT cells receive IL-15 by different cell-types (mTEC, DCs, and 
Ito cells) these cells express similar co-stimulatory molecules 118,121. Thus, 
dissecting the interaction of iNKT cells with mTEC, DCs, and Ito cells may reveal 
why iNKT cells appear to be functionally a heterogeneous population of invariant T 
cells.  
 
4.2.2 The function of IL-15 during iNKT cell development and homeostasis. 
IL-15 has previously been shown to be critical for the survival and expansion of 
iNKT cells 34,111. On the other hand, the role of IL-15 in other aspects of iNKT cell 
biology such as function and activation has remained unexplored. During iNKT cell 
development, thymic and peripheral iNKT cells undergo cellular survival and 
multiple developmental events including cellular expansion, differentiation and 
retention (thymic iNKT cells). Of these events, I found IL-15 mediated the survival of 
thymic iNKT cells by maintaining high levels of the anti-apoptotic molecule, Bcl-2. In 
the periphery, IL-15 was vital for both survival (Bcl-2 mediated) and proliferation of 
iNKT cells. Once again, I found that the location was an instrumental aspect in 
determining the effects of IL-15 in iNKT cell biology. 
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Additionally, I revealed IL-15 is critical in both the functional maturation and 
activation of iNKT cells. T-bet is known to induce the terminal maturation of iNKT 
cells by regulating the expression of various cell surface receptors like NK1.1, 
CD122, and CXCR3 as well as effector molecules like IFN-γ, granzyme b and 
perforin 116.  Interestingly, iNKT cells derived from IL-15Rα-/- mice expressed low 
levels of T-bet and CD122, and upon activation produced very low levels of IFN-γ 
(hepatic iNKT cells). Surprisingly, normal expression levels of NK1.1 and CXCR3 
(thymic iNKT cells) were observed on iNKT cells developing in IL-15Rα-/- mice. In 
the thymus, I speculate that once T-bet is expressed it initiates the transcription and 
subsequent expression of NK1.1, CXCR3, and CD122 by iNKT cells. CXCR3 
expression directs iNKT cells to the thymic medullary epithelium where they receive 
an IL-15 signal. Seeing IL-15 increases T-bet levels which further enhances CD122 
expression consequently making iNKT cells more responsive to IL-15. 
 
As previously mentioned, T-bet also regulates IFN-γ, granzyme b and perforin 
expression 116. Whether IL-15 affects the effector function of thymic iNKT cells is 
unclear given that thymic iNKT cells do not respond to αGalCer in vivo. It is 
plausible to think thymic iNKT cells are just not functionally mature. On the contrary, 
it is clear that IL-15 signaling is essential for the functional maturation of hepatic 
iNKT cells. But why would IL-15 turn on the effector program only in the periphery 
but not in the thymus? Perhaps, this is why iNKT cells have evolved to obtain IL-15 
from different cellular sources depending on the tissue site they reside. So although 
non-hematopoietic cells can provide IL-15 to iNKT cells in the periphery it is 
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possible IL-15 trans-presentation by hematopoietic cells endows iNKT cells with 
effector function. So once again, the tissue microenvironment where iNKT cells 
reside determines the function of IL-15. 
 
4.2.3 Conclusion. 
In summary, the tissue microenvironment influences iNKT cells at different stages of 
development as well as regulates their function. By restricting IL-15Rα expression 
to certain cellular compartments, I was able to better define the cell-types trans-
presenting IL-15 to iNKT cells in the various tissues. Depending on the tissue, IL-15 
regulates the survival and/or proliferation of iNKT cells as well as impacts the 
functional status of iNKT cells. Overall, identification of the various cell-types 
providing IL-15 to iNKT cells could prove invaluable for improving iNKT cell adoptive 
immunotherapy and manipulating the immune response in specific tissue 
microenvironments. 
 
4.3 General Discussion. 
4.3.1 Exploitation of NK and iNKT cells. 
Recognizing the factors that assist in the generation of a functional immune system 
can easily be utilized in translational research. This vital knowledge enables 
scientists and clinicians the ability to manipulate lymphocytes for adoptive transfer 
therapies treating immunocompromised patients or individuals suffering from life 
threatening diseases. Additionally, understanding the reconstitution of the immune 
system is extremely important in HSCT patients who are susceptible to numerous 
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opportunistic infections. Two immune cells that show great potential in the clinic are 
NK and iNKT cells as both have been shown to be crucial in tumor and viral 
immunity 38,148.  
 
Currently, graft-versus host disease (GVHD) is a major hindrance in cancer patients 
receiving allogeneic hematopoietic stem cell transplantation (HSCT) 149. GVHD is a 
life-threatening condition that occurs when donor immune cells launch a massive 
immunological attack on the various tissues of the recipient. GVHD is initiated when 
the patient receives a conditioning regimen (chemotherapy or irradiation) to deplete 
the host immune cells. This treatment damages the host tissue which inevitably 
causes the activation of donor antigen presenting cells (e.g. DCs) via the release of 
proinflammatory cytokines being produced by damaged tissues and the release of 
lipopolysaccharide (LPS) from the intestine. These activated DCs present host 
antigen to donor T cells which then attack various tissues in the host. In addition, 
activated donor T cells can also cause Graft versus tumor (GVT) but at the cost of 
normal tissue damage. Depletion of donor T cells before transplantation has 
reduced the risk of GVHD; however, the reoccurrence of this condition is 
substantially higher 150. Thus, immune effector cells, like T cells, are essential for 
GVT but preventing GVHD is crucial for patient health and survival.  
 
NK cells have recently been shown to provide the GVT effect with little to no GVHD 
151
. The basis behind this GVT effect was dependent on NK cells expressing killer-
cell immunoglobulin-like receptors (KIR) 152. KIRs can be activating or inhibitory and 
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the inhibitory KIRs interact with various human leukocyte antigens (HLA). This KIR-
HLA interaction is analogous to the Ly49-MHC interaction in mice which results in 
NK cell education 44,153.  Thus, educated NK cells can detect “missing self” via KIR-
HLA incompatibility which would result in target cytolysis. In humans and mouse 
models, the presence of NK cells have been shown to enhance BM engraftment as 
well as display strong anti-tumor activity in the recipient receiving both T cell-
depleted allogeneic HSCT and NK cells infusion 154. Suggestions have been made 
that NK cells assist in graft acceptance by killing donor T cells, inducing GVT by 
killing HLA-mismatched tumors, and preventing GVHD by killing host DCs and 
prevention of donor T cell activation 151,152. Thus, understanding what regulates KIR 
expression in NK cells is essential for GVT and studies like mine provide key clues 
in enhancing our understanding in NK cell receptor regulation. 
 
Regarding iNKT cells in the clinic, the ability to skew the cytokine profile of iNKT 
cells with various modified glycolipids and their capacity to cross-talk with DCs and 
macrophages, highlights their potential in various pathological states driven by 
distinct cytokines (Th1 versus Th2). Thus, the proper manipulation of iNKT cells can 
prove beneficial in the prevention of various autoimmune diseases and various 
cancers 148. Additionally, both host and donor iNKT cells have also been shown to 
be critical in preventing GVHD and inducing GVT, respectively. Preventing GVHD is 
due to iNKT cells ability to produce Th2 cytokines 155 and the conditioning regiment 
enhances host iNKT cell function 156. On the other hand, donor iNKT cells have 
been shown to induce GVT in the absence of GVHD 157. Overall, the significant role 
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of NK and iNKT cells in immunosurveillance makes knowledge of their 
immunological niche very important in understanding their roles at steady-state and 
pathophysiological conditions, critical but lacking knowledge.  
 
The foundation of generating functionally mature NK and iNKT cells relies on the 
various cellular and molecular cues acquired throughout development. Additionally, 
the occupation of various tissue microenvironments by NK and iNKT cells provides 
an additional factor contributing to these functional attributes. One such factor being 
provided by the tissue microenvironment is the cytokine IL-15. However, how IL-15 
regulated these various events and what cell-type provides IL-15 for these two 
different IL-15-dependent populations was unknown. This lack of knowledge and 
the fact that the requirement of IL-15 is similar in NK and iNKT cell biology 
demanded immediate attention. 
 
Therefore, my goal was to identify the cellular cues which govern the generation of 
these two lymphocytes thus utilizing these cues for immunological control or 
manipulation. Independently, each of my aims has contributed to the understanding 
and biological diversity of IL-15 in generating a functional immune system. 
Specifically, I have demonstrated that IL-15 is an essential factor involved in the 
differentiation, functional maturation, proliferation, survival and homeostasis of NK 
and iNKT cells. In conclusion, this study will prove pioneering and exploitable, as it 
utilized established models and techniques to address when and where IL-15 trans-
presentation is important in NK and iNKT cell biology. 
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CHAPTER 5 
 
MATERIALS AND METHODS 
 
5.1 Mice. 
C57BL/6J (CD45.1 and CD45.2) mice were purchased from The Jackson 
Laboratories (Bar Harbor, ME) and NCI (Bethesda, MD). IL-15Rα-/- mice were 
generously provided by A. Ma (UCSF) and backcrossed to C57BL/6 mice 15 
generations. CD11c/IL-15Rα Tg mice backcrossed to the IL-15Rα-/- background 
were generated in our laboratory and described elsewhere 35. Tg founder line no. 1 
was used throughout this study and characterized as having IL-15Rα expression 
restricted to CD11c+ cells. Tg positive mice were identified by PCR of tail DNA and 
confirmed by IL-15Rα staining on CD11c+ cells. Mice were 6-14 wk of age when 
used in the various experiments.  All mice were maintained under specific 
pathogen-free conditions at the University of Texas M.D. Anderson Cancer Center 
in accordance with the Institutional Animal Care and Use Committee guidelines. 
5.2 Generation of BM chimeras.  
BM was collected from the tibia and femurs of IL-15Rα–/– (CD45.1 or 
CD45.1/CD45.2) and C57BL/6J (CD45.1) mice by crushing with mortal and pestle. 
T cells were removed from the isolated BM cells by treating with anti-Thy1 mAb (30 
H12), followed by the incubation of Low-Tox-M rabbit complement (Cedarlane 
Laboratories) for 1 h at 37°C. IL-15Rα–/– (CD45.2) and C57BL/6J (CD45.2) 
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recipients were irradiated with 1000 cGy and injected i.v. with 3 x 106 BM cells. In 
some experiments, BM cells from IL-15Rα–/– (CD45.1/CD45.2) and C57BL/6J 
(CD45.2) were mixed in equal proportions before injecting into irradiated C57BL/6J 
(CD45.1) recipients. Chimera mice were analyzed for the presence of donor NK 
cells in the BM, liver, and spleen 8–12 wk later after complete BM reconstitution.  
5.3 Lymphocyte isolation and Flow Cytometry. 
BM cells were isolated by flushing a femur and tibia with HBSS/HGPG and filtering 
through a 70-µm nitex. Thymus and spleens were homogenized in HBSS containing 
Hepes, L-glutamine, gentamycin and pen-strep (HGPG) using frosted slides and 
filtering through 70 µm nitex. Livers were collected after intracardiac perfusion with 
PBS containing heparin, minced, and digested in RPMI with 10% FBS and 150 U/ml 
collagenase (Invitrogen). Remaining tissue was pressed through a 70 mm cell 
strainer and lymphocytes were isolated with a 44-67% Percoll (Amersham) gradient. 
When analyzing NK cells, single cell-suspensions were stained with the indicated 
Abs obtained from BD Biosciences (CD3 (17A2)-FITC, CD122-PE, NK1.1-PerCP-
Cy5.5, CD11b-PE-Cy7, CD49b (DX5)-PE, Ly5.2 (CD45.1)-PE, CD94-PE, and 
CD69-Pe-Cy7) or eBioscience (Ly49 C/I/F/H-FITC, Ly49 G2 (4D11)-FITC, Ly49 I 
(YLI-90)-PE, Ly49 A/D-PE, CD49b (DX5) allophycocyanin, KLRG1 allophycocyanin, 
NKG2D (CD314) allophycocyanin, Ly49 H (3D10)-AlexaFluor 647, CD107a (1D4B)-
AlexaFluor 647, and NKG2 A/C/E (20d5)-biotin) and Biolegend (Ly49 A PB, CD43 
allophycocyanin and TCRβ allophycocyanin AlexFluor 750). With regards to iNKT 
cells, cells were first stained with CD1d-PBS57 loaded tetramer allophycocyanin-
conjugated (NIH Tetramer Facility) for 30 minutes in the dark at 37°C then washed 
 132 
and followed by other indicated cell surface markers. The indicated antibodies were 
obtained from BD Bioscience (San Jose, CA) CD3 (17A2)-FITC, TCRb (H57)-
FITC,CD45.2 (104)-FITC, CD45.1 (A20)-PE, CD44 (IM7)-PE, CD122 (TM-b1)-PE, 
IFN-γ-PE, NK1.1 (PK136)-PE, NK1.1-PerCP-Cy5.5, CD45.2 (104)- PerCP-Cy5.5, 
CD4 (RM4-5)-PE-Cy7 or eBioscience (San Diego, CA) T-bet-PE (eBio4B10), 
CD45.2 (104)-Allophycocyanin-Cy7, CD44 (IM7)-eFluor™ 450; and Biolegend (San 
Diego, CA) CD94(18d3)-Pacific Blue, CD45.1 (A20)-Pacific Blue and  CD45.1 
(A20)-Allophycocyanin-Cy7and TCRβ Allophycocyanin-AlexFluor 750. To detect 
Bcl-2 in iNKT cells, intracellular staining was performed using BD cytofix/cytoperm 
kit (BD Bioscience, San Jose, CA) and stained with anti-mouse Bcl-2 FITC. To 
analyze T-bet expression by iNKT cells, intracellular staining was performed using 
eBioscience Foxp3 staining buffer set. All samples were collected on a LSR II Flow 
Cytometry (BD Bioscience) and data were analyzed with FlowJo software (Treestar, 
San Carlos, CA).  
5.4 Cell cycle labeling.  
For long-term labeling in NK cells, mice were administered water supplemented with 
BrdU (0.8 mg/ml). BrdU-supplemented water was changed every 2 days for 3 wk. 
Long-term BrdU labeling in iNKT cells, mice were administered water supplemented 
with BrdU (0.8mg/ml). BrdU supplemented water was changed every day for one 
week. BrdU Flow kit (BD Pharmingen) and protocol was used to analyze NK and 
iNKT cell incorporation of BrdU. Cell surface stains included markers to identify 
individual development stages for NK cells and iNKT cells. Cells were then fixed 
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and permeabilized using BD cytofix/cytoperm buffer, followed by DNase (30 µg) 
treatment. Cells were then stained with anti-BrdU FITC for 20 min at room 
temperature and analyzed as stated above.  Cells were then stained with anti-BrdU 
FITC for 20 min at room temperature and analyzed as stated above. 
5.5 Adoptive transfer.  
To enrich for NK cells, 10–15 spleens were pooled from C57BL/6J (CD45.1) mice 
and incubated with rat anti-CD8 (2.43), anti-CD4 (Gk1.5), anti-CD19 (1D3), and 
anti-MHC II (M5), followed by washing and a subsequent incubation with goat anti-
rat Dynabeads (Dynal Biotech). Magnetic-coated cells were then removed with a 
magnet. Enriched cells were CFSE-labeled, and 7–10 x 106 cells were injected i.v. 
into IL-15Rα–/– (CD45.2), CD11c/IL-15Rα Tg (CD45.2), and C57BL/6J (CD45.2) 
mice. Three weeks later, mice were sacrificed, the BM, liver, and spleen were 
harvested, and donor cells were analyzed for cell surface phenotype and cellular 
division by flow cytometry. For iNKT cell enrichment, 10 -15 thymuses were pooled 
from C57BL/6J (CD45.1) mice and incubated with rat anti-CD8 (2.43), anti-CD19 
(1D3), anti-MHC II (M5) followed by washing and a subsequent incubation with goat 
anti-rat Dynabeads and then magnetic cells were removed as previously described. 
In experiments examining homeostasis, enriched cells were labeled with the 
fluorescent cell staining dye, Carboxyfluorescein succinimidyl ester (CFSE), and 5-8 
x 106 cells were injected i.v. into IL-15Rα-/- (CD45.2), CD11c/IL-15Rα Tg (CD45.2) 
or C57BL/6J (CD45.2) mice. Seven days after transfer, tissues were harvested and 
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analyzed for the presence of donor cells and CFSE dilution by flow cytometry. For 
αGalCer stimulation, mice were sacrificed 2 days after transfer of donor cells. 
 
5.6 DC-NK cell coculture system.  
Spleens from four to five CD11c/IL-15Rα Tg or WT mice were pooled and enriched 
for NK cells as previously described above. Enriched cells were stained with CD3, 
NK1.1, Ly49 C/I/F/H, and Ly49 A/D and then sorted on the FACSAria II cell sorter 
(BD Biosciences). Sorted population contained a NK1.1+ Ly49– CD3– cells, which 
were used for coculturing with C57BL/6J and IL-15Rα–/– DC. DC derived from 
C57BL/6J and IL-15Rα–/– mice were generated by culturing BM-derived cells with 
GM-CSF at 1000 U/ml supplemented complete media (RPMI 1640, 10% heat-
inactivated FCS, 10 mM HEPES, and 50 µM 2-ME). Cells were washed and fed 
every 2 days for 7 days. BM-derived DC were then collected and cocultured at a 1:3 
ratio with NK cells negative for Ly49 C/I/F/H and A/D. After 5 days, NK cells were 
then stained for CD3, NK1.1, Ly49 C/I/F/H, and Ly49 A/D cell surface markers and 
analyzed by flow cytometry as described previously.  
5.7 IFN-γ and CD107α stimulation assay.  
Spleens from four to five CD11c/IL-15Rα or WT were pooled, enriched for NK cells 
as previously described above. NK1.1+CD3– cells were sorted from the enriched 
fraction on the FACSAria II cell sorter (BD Biosciences) and incubated for 5 h in the 
absence or presence of plate-bound anti-NK1.1 Ab at 37°C as described previously 
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44
. Cultures were supplemented with 1 µl of CD107a (1D4B) Ab and 1 µl of 
GolgiPlug (BD Biosciences). The cells were then fixed and permeabilized using BD 
Cytofix/Cytoperm buffers and stained with PE-conjugated anti-IFN-γ or control Ig 
mAb (BD Biosciences) as well as CD3 and NK1.1 and analyzed via flow cytometry.  
5.8 In vivo α−Galactosylceramide  and IL-15/IL-15Rα-Fc Complex stimulation. 
α-Galactosylceramide (2 µg/mouse) (Funakoshi co., Itd Tokyo, Japan) diluted in 1x 
PBS was injected i.v. into the various mice. Tissues were collected and processed 
as previously described 2.5 hrs post-injection. Single cell suspensions were 
supplemented with 2 µL of GolgiStop (BD Bioscience, San Jose, CA) for 1 h at 37 
°C. After staining for cell surface markers, cells were then fixed and permeabilized 
and stained with PE-conjugated anti-IFN-γ as previously described and analyzed via 
flow cytometry.  When analyzing the effects of IL-15 signaling in IL-15Rα-/- mice 
prior to αGalCer stimulation (sacrificed 2d later) or T-bet expression (sacrificed 1d 
later), each mouse received an i.p. injection of 2.5 µg of recombinant murine IL-15 
(PeproTech, Rocky Hill, NJ) precomplexed to 15µg of recombinant IL-15Rα/Fc 
chimera (R&D Systems) 137. To briefly explain the formation of the complex, 2.5 µg 
of recombinant murine IL-15 resuspended in 1x sterile PBS was mixed and 
incubated for 30 minutes at room temperature with 15 µg of recombinant IL-
15Rα/Fc chimera resuspended in 1x sterile PBS supplemented with 0.1% BSA.  
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5.9 Statistical Analysis.  
Graphs generated display the mean ± standard error of the mean (S.E.M.) and were 
obtained using GraphPad Prism software (GraphPad Software, La Jolla, CA).  
Statistical significance was assessed by performing an unpaired Student’s t test. 
Data collected from experimental mice (chimeras where IL-15Rα was restricted to 
either hematopoietic or non-hematopoietic cells, or Tg mice) was compared to the 
data generated from mice completely lacking IL-15Rα-/- unless the data was only 
comparing IL-15Rα-/- and WT control mice. 
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